• Adak M, Gupta JK. Evaluation of anti-inflammatory activity of Calotropis gigantea (AKANDA) in various biological system. Nepal. Med. Coll. J. 8: 156-161 (2006).

• Ahishali E, Pinarbasi B, Akyuz F, Ibrisim D, Kaymakoglu S, Mungan Z. A case of Aeromonas hydrophila enteritis in the course of ulcerative colitis. Eur. J. Intern. Med. 18: 430-431 (2007).

• Ajjan RA, Weetman AP. New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy. J. Endocrinol. Invest. 27: 237-245 (2004).

• Ajonuma LC, He Q, Sheung Chan PK, Yu Ng EH, Fok KL, Yan Wong CH, Tsang LL, Ho LS, Lau MC, Huang HY, Yang DZ, Rowlands DK, Tang XX, Zhang XH, Chung YW, Chan HC. Involvement of cystic fibrosis transmembrane conductance regulator in infection-induced edema. Cell Biol. Int. 32: 801-806 (2008). *

• Akcali C, Ozkur M, Erbagci Z, Benlier N, Aynacioglu AS. Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with angio-oedema accompanying chronic urticaria but not chronic urticaria without angio-oedema or the autologous serum skin test response. J. Eur. Acad. Dermatol. Venereol. 22: 83-86 (2008). *

• Al-Kateb H, Mirea L, Xie X, Sun L, Liu M, Chen H, Bull SB, Boright AP, Paterson AD. Multiple variants in vascular endothelial growth factor (VEGF) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study. Diabetes 56: 2161-2168 (2007). *

• Alaminos M, Gonzalez-Andrades M, Munoz-Avila JI, Garzon I, Sanchez-Quevedo MC, Campos A. Volumetric and ionic regulation during the in vitro development of a corneal endothelial barrier. Exp. Eye Res. 86: 758-769 (2008).

• Albrecht J. Glucose-derived osmolytes and energy impairment in brain edema accompanying liver failure: the role of glutamine reevaluated. Gastroenterology 125: 976-978 (2003). *

• Albrecht J, Atzeni F, Baldini C, Bombardieri S, Dalakas MC, Demirkesen C, Yazici H, Mat C, Werth VP, Sarzi-Puttini P. Skin involvement and outcome measures in systemic autoimmune diseases. Clin. Exp. Rheumatol. 24: S52-S59 (2006).

• Albrecht J, Dolinska M. Glutamine as a pathogenic factor in hepatic encephalopathy. J. Neurosci. Res. 65: 1-5 (2001).

• Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 44: 788-794 (2006). *

• Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L, Hennekam EA, Holmberg EE, Mannens MM, Mulder MF, Offerhaus GJ, Prescott TE, Schroor EJ, Verheij JB, Witte M, Zwijnenburg PJ, Vikkula M, Schulte-Merker S, Hennekam RC. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat. Genet. 41: 1272-1274 (2009). *

• Alevizaki M, Mantzou E, Cimponeriu A, Saltiki K, Philippou G, Wiersinga W. The Pro(12)Ala PPARgamma gene polymorphism: possible modifier of the activity and severity of thyroid associated orbitopathy (TAO). Clin. Endocrinol. (Oxf.) 70: 464-468 (2009). *

• Alexander JJ, Jacob A, Cunningham P, Hensley L, Quigg RJ. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem. Int. 52: 447-456 (2008).

• Alhajeri A, Erwin S. Acute pancreatitis: value and impact of CT severity index. Abdom. Imaging 33: 18-20 (2008). *

• Aliaga L, Mediavilla JD, Omar M, Zozaya JM, Prieto J. Directional velocity of the arterial flow, systemic vascular resistance and urinary excretion of sodium in cirrhotic patients. Presse. Med. 24: 758-762 (1995).

• Allahtavakoli M, Shabanzadeh A, Roohbakhsh A, Pourshanazari A. Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats. Basic Clin. Pharmacol. Toxicol. 101: 309-314 (2007). *

• Alnounou M, Munoz SJ. Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf] Practical Gastroenterology April 2006: 92-100 (2006). *

• Amigo M, Paya M, Braza-Boils A, De Rosa S, Terencio MC. Avarol inhibits TNF-alpha generation and NF-kappaB activation in human cells and in animal models. Life Sci. 82: 256-264 (2008). *

• Amigo M, Paya M, De Rosa S, Terencio MC. Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin. Br. J. Pharmacol. 152: 353-365 (2007). *

• Amin AI, Shaikh IA. Topical negative pressure in managing severe peritonitis: a positive contribution? World J. Gastroenterol. 15: 3394-3397 (2009). *

• Ammar D, Denguezli M, Ghariani N, Sriha B, Belajouza C, Nouira R. Sweet's syndrome complicating isotretinoin therapy in acne. Ann. Dermatol. Venereol. 134: 151-154 (2007).

• Anandarajah AP, Ory P, Salonen D, Feng C, Wong RL, Ritchlin CT. Effect of adalimumab on joint disease features of patients with psoriatic arthritis detected by magnetic resonance imaging. Ann. Rheum. Dis. 69: 206-209 (2010).

• Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann. Neurol. 55: 654-659 (2004). *

• Andrade MC, Menezes JS, Cassali GD, Martins-Filho OA, Cara DC, Faria AM. Alcohol-induced gastritis prevents oral tolerance induction in mice. Clin. Exp. Immunol. 146: 312-322 (2006). *

• Anshu A, Chee SP. Posterior scleritis and its association with HLA B27 haplotype. Ophthalmologica 221: 275-278 (2007).

• Ansquer JC, Foucher C, Aubonnet P, Le Malicot K. Fibrates and microvascular complications in diabetes - insight from the FIELD study. Curr. Pharm. Des. 15: 537-552 (2009).

• Aquila S, Rojano B, Recio MC, Giner RM, Schinella GR, Debenedetti SL, Saez J, Rios JL. Anti-inflammatory activity of berenjenol and related compounds. Planta Med. 75: 18-23 (2009).

• Arafa HM, Hemeida RA, El-Bahrawy AI, Hamada FM. Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model. Food Chem. Toxicol. 47: 1311-1317 (2009). *

• Araico A, Terencio MC, Alcaraz MJ, Dominguez JN, Leon C, Ferrandiz ML. Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor. Life Sci. 80: 2108-2117 (2007). *

• Armstrong CP, Taylor TV, Torrance HB. Effects of bile, infection and pressure on pancreatic duct integrity. Br. J. Surg. 72: 792-795 (1985).

• Asada Y, Isomoto H, Shikuwa S, Wen CY, Fukuda E, Miyazato M, Okamoto K, Nakamura T, Nishiyama H, Mizuta Y, Migita K, Ito M, Kohno S. Development of ulcerative colitis during the course of rheumatoid arthritis: association with selective IgA deficiency. World J. Gastroenterol. 12: 5240-5243 (2006). *

• Asero R, Riboldi P, Tedeschi A, Cugno M, Meroni P. Chronic urticaria: a disease at a crossroad between autoimmunity and coagulation. Autoimmun. Rev. 7: 71-76 (2007).

• Aszalos Z. Some neurological and psychiatric complications in the disorders of the thyroid gland. Orv. Hetil. 148: 303-310 (2007).

• Atkins EJ, Biousse V, Newman NJ. The natural history of optic neuritis. Rev. Neurol. Dis. 3: 45-56 (2006).

• Auli M, Fernandez E. Characterization of functional and morphological changes in a rat model of colitis induced by Trichinella spiralis. Dig. Dis. Sci. 50: 1432-1443 (2005). *

• Auricchio L, Vitiello L, Adriani M, Ferri P, Chiocchetti A, Pettinato G, Racioppi L, Maiuri L, Dianzani U, Pignata C. Cutaneous manifestations as presenting sign of autoimmune lymphoproliferative syndrome in childhood. Dermatology 210: 336-340 (2005).

• Autret-Leca E, Jonville-Bera AP, Beau-Salinas F. Vaccines pharmacovigilance. Rev. Prat. 54: 526-531 (2004).

• Auzinger G, Wendon J. Intensive care management of acute liver failure. Curr. Opin. Crit. Care 14: 179-188 (2008).

• Ayala de la Cruz Mdel C, Gonzalez Diaz R, Lopez Lara ND. Wegener's granulomatosis. Report of a pediatric case and review of the literature. Rev. Alerg. Mex. 50: 71-75 (2003).

• Aydin E, Demir HD, Ozyurt H, Etikan I. Association of plasma homocysteine and macular edema in type 2 diabetes mellitus. Eur. J. Ophthalmol. 18: 226-232 (2008).

• Aydin O, Engin B, Oguz O, Ilvan S, Demirkesen C. Non-pustular palmoplantar psoriasis: is histologic differentiation from eczematous dermatitis possible? J. Cutan. Pathol. 35: 169-173 (2008).

• Babu S, Bhat SQ, Pavan Kumar N, Lipira AB, Kumar S, Karthik C, Kumaraswami V, Nutman TB. Filarial lymphedema is characterized by antigen-specific Th1 and Th17 proinflammatory responses and a lack of regulatory T cells. PLoS Negl. Trop. Dis. 3: e420 (2009). *

• Bachs L, Pares A, Elena M, Piera C, Rodes J. Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology 102: 2077-2080 (1992).

• Bailey E, Shaker M. An update on childhood urticaria and angioedema. Curr. Opin. Pediatr. 20: 425-430 (2008).

• Balakrishnan V, Chatni S, Radhakrishnan L, Narayanan VA, Nair P. Groove pancreatitis: a case report and review of literature. JOP 8: 592-597 (2007). *

• Ballester I, Gonzalez R, Nieto A, Zarzuelo A, Sanchez de Medina F. Monochloramine induces acute and protracted colitis in the rat: response to pharmacological treatment. Life Sci. 76: 2965-2980 (2005). *

• Barkham N, Keen HI, Coates LC, O'Connor P, Hensor E, Fraser AD, Cawkwell LS, Bennett A, McGonagle D, Emery P. Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum. 60: 946-954 (2009). *

• Bartlett AH, Foster TJ, Hayashida A, Park PW. alpha-Toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J. Infect. Dis. 198: 1529-1535 (2008). *

• Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am. J. Neuroradiol. 27: 2179-2190 (2006). *

• Batra Y, Acharya SK. Acute liver failure: prognostic markers. Indian J. Gastroenterol. 22 Suppl. 2: S66-S68 (2003).

• Bauerova K, Kucharska J, Mihalova D, Navarova J, Gvozdjakova A, Sumbalova Z. Effect of coenzyme Q(10) supplementation in the rat model of adjuvant arthritis. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub. 149: 501-503 (2005).

• Beckebaum S, Cicinnati V, Broelsch CE. Liver transplantation, rejection and disease recurrence. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 55-56. October 15-16 (2003). *

• Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355: 2297-2307 (2006). *

• Bellinger DL, Lorton D, Brouxhon S, Felten S, Felten DL. The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation. Adv. Neuroimmunol. 6: 5-27 (1996).

• Beltran E, Toll A, Pros A, Carbonell J, Pujol RM. Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon. Br. J. Dermatol. 156: 892-898 (2007). *

• Bemeur C, Qu H, Desjardins P, Butterworth RF. IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure. Neurochem. Int. Nov 17 [Epub ahead of print] (2009).

• Ben M'rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, Guesmi M, Rollot F, Dehoux M, Guillevin L, Moachon L. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine (Baltimore) 88: 131-140 (2009).

• Bennett AN, McGonagle D, O'Connor P, Hensor EM, Sivera F, Coates LC, Emery P, Marzo-Ortega H. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum. 58: 3413-3418 (2008). *

• Benucci M, Manfredi M, Saviola G, Baiardi P, Campi P. Correlation between atopy and hypersensitivity reactions during therapy with three different TNF-alpha blocking agents in rheumatoid arthritis. Clin. Exp. Rheumatol. 27: 333-336 (2009).

• Berdiev BK, Benos DJ. Epithelial sodium channel in planar lipid bilayers. Methods Mol. Biol. 337: 89-99 (2006).

• Berger-Achituv S, Ellis MH, Curtis BR, Wolach B. Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent. Am. J. Hematol. 83: 676-678 (2008). *

• Bergersen TK, Mork C. A 62-year-old woman with non-pitting leg oedema. Tidsskr. Nor. Laegeforen. 129: 750-752 (2009).

• Bergquist A, Montgomery SM, Lund U, Ekbom A, Olsson R, Lindgren S, Prytz H, Hultcrantz R, Broome U. Perinatal events and the risk of developing primary sclerosing cholangitis. World J. Gastroenterol. 12: 6037-6040 (2006). *

• Bernstein JM, Anon JB, Rontal M, Conroy J, Wang C, Sucheston L. Genetic polymorphisms in chronic hyperplastic sinusitis with nasal polyposis. Laryngoscope 119: 1258-1264 (2009).

• Bernthal P, Hays A, Tarter RE, Van Thiel D, Lecky J, Hegedus A. Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance. Hepatology 7: 107-114 (1987).

• Bhalla V, Hallows KR. Mechanisms of ENaC regulation and clinical implications. J. Am. Soc. Nephrol. 19: 1845-1854 (2008). *

• Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controlled clinical trial. J. Hepatol. 41: 89-96 (2004). *

• Bhonde MR, Gupte RD, Dadarkar SD, Jadhav MG, Tannu AA, Bhatt P, Bhatia DR, Desai NK, Deore V, Yewalkar N, Vishwakarma RA, Sharma S, Kumar S, Dagia NM. A novel mTOR inhibitor is efficacious in a murine model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G1237-G1245 (2008). *

• Bhoomagoud M, Jung T, Atladottir J, Kolodecik TR, Shugrue C, Chaudhuri A, Thrower EC, Gorelick FS. Reducing extracellular pH sensitizes the acinar cell to secretagogue-induced pancreatitis responses in rats. Gastroenterology 137: 1083-1092 (2009). *

• Bianco F, Fattapposta F, Locuratolo N, Pierallini A, Rossi M, Ruberto F, Bozzao L. Reversible diffusion MRI abnormalities and transient mutism after liver transplantation. Neurology 62: 981-983 (2004).

• Bieri M, Oroszlan M, Farkas A, Ligeti N, Bieri J, Mohacsi P. Anti-HLA I antibodies induce VEGF production by endothelial cells, which increases proliferation and paracellular permeability. Int. J. Biochem. Cell Biol. 41: 2422-2430 (2009). *

• Bilezikci B, Demirhan B, Kocbiyik A, Arat Z, Haberal M. Relevant histopathologic findings that distinguish acute cellular rejection from cholangitis in hepatic allograft biopsy specimens. Transplant. Proc. 40: 248-250 (2008). *

• Blei AT. Brain edema in acute liver failure: can it be prevented? Can it be treated? J. Hepatol. 46: 564-569 (2007). *

• Boada A, Bielsa I, Fernandez-Figueras MT, Ferrandiz C. Perniosis: clinical and histopathological analysis. Am. J. Dermatopathol. 32: 19-23 (2010).

• Boberg KM, Schrumpf E. Prognosis of autoimmune liver diseases. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 81 (2004). *

• Boden G, Zhang M. Recent findings concerning thiazolidinediones in the treatment of diabetes. Expert Opin. Investig. Drugs 15: 243-250 (2006).

• Boin F, Hummers LK. Scleroderma-like fibrosing disorders. Rheum. Dis. Clin. North Am. 34: 199-220 (2008). *

• Bokszczanin A, Levinson AI. Coexistent yellow nail syndrome and selective antibody deficiency. Ann. Allergy Asthma Immunol. 91: 496-500 (2003).

• Bol-Schoenmakers M, Fiechter D, Raaben W, Hassing I, Bleumink R, Kruijswijk D, Maijoor K, Tersteeg-Zijderveld M, Brands R, Pieters R. Intestinal alkaline phosphatase contributes to the reduction of severe intestinal epithelial damage. Eur. J. Pharmacol. Feb 1 [Epub ahead of print] (2010). *

• Bonel HM, Boller C, Saar B, Tanner S, Srivastav S, Villiger PM. Short term changes in magnetic resonance Imaging and disease activity in response to infliximab. Ann. Rheum. Dis. 69: 120-125 (2010).

• Bonfioli AA, Damico FM, Curi AL, Orefice F. Intermediate uveitis. Semin. Ophthalmol. 20: 147-154 (2005).

• Bongartz T, Coras B, Vogt T, Scholmerich J, Muller-Ladner U. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study. Rheumatology (Oxford) 44: 126-129 (2005). *

• Bonheur JL, Braunstein J, Korelitz BI, Panagopoulos G. Anal skin tags in inflammatory bowel disease: new observations and a clinical review. Inflamm. Bowel Dis. 14: 1236-1239 (2008). *

• Bougacha-Elleuch N, Rebai A, Mnif M, Makni H, Bellassouad M, Jouida J, Abid M, Hammadi A. Analysis of MHC genes in a Tunisian isolate with autoimmune thyroid diseases: implication of TNF -308 gene polymorphism. J. Autoimmun. 23: 75-80 (2004).

• Brenner M, Herzinger T, Berking C, Plewig G, Degitz K. Phototherapy and photochemotherapy of sclerosing skin diseases. Photodermatol. Photoimmunol. Photomed. 21: 157-165 (2005).

• Bressan E, De Queiroz Cunha F, Tonussi CR. Contribution of TNFalpha, IL-1beta and CINC-1 for articular incapacitation, edema and cell migration in a model of LPS-induced reactive arthritis. Cytokine 36: 83-89 (2006).

• Brickman CM, Tsokos GC, Balow JE, Lawley TJ, Santaella M, Hammer CH, Frank MM. Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. J. Allergy Clin. Immunol. 77: 749-757 (1986).

• Brodsky B, Erlanger-Rosengarten A, Proscura E, Shapira E, Wormser U. From topical antidote against skin irritants to a novel counter-irritating and anti-inflammatory peptide. Toxicol. Appl. Pharmacol. 229: 342-350 (2008). *

• Brophy CM, Nyberg SL. Extracorporeal treatment of acute liver failure. Hepatol. Res. 38 (s1: The 6 Japan Society of Hepatology Single Topic Conference: Liver Failure: Recent Progress and Pathogenesis to Management. 28-29 September 2007, Iwate, Japan): S34-S40 (2008). *

• Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 54: 3761-3773 (2006). *

• Brzezinska-Wcislo L, Bergler-Czop B, Lis-Swiety A. Sonozaki syndrome: case report and review of literature. Rheumatol. Int. Jan 5 [Epub ahead of print] (2010). *

• Bucciarelli S, Espinosa G, Asherson RA, Cervera R, Claver G, Gomez-Puerta JA, Ramos-Casals M, Ingelmo M, Font J. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann. Rheum. Dis. 65: 81-86 (2006). *

• Buchman AL, Moukarzel AA, Bhuta S, Belle M, Ament ME, Eckhert CD, Hollander D, Gornbein J, Kopple JD, Vijayaroghavan SR. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J. Parenter. Enteral Nutr. 19: 453-460 (1995).

• Bucova M, Bernadic M, Buckingham T. C-reactive protein, cytokines and inflammation in cardiovascular diseases. Bratisl. Lek. Listy. 109: 333-340 (2008).

• Burch LH, Picher M. E-NTPDases in human airways: regulation and relevance for chronic lung diseases. Purinergic Signal. 2: 399-408 (2006). *

• Burkhardt Soares S, Fehr A, Brandt AS, Roth S. Retroperitoneal fibrosis. Aktuelle. Urol. 38: 221-231 (2007).

• Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA. Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes. Clin. Ther. 27: 1181-1195 (2005). *

• Butterworth MB, Edinger RS, Frizzell RA, Johnson JP. Regulation of the epithelial sodium channel (ENaC) by membrane trafficking. Am. J. Physiol. Renal Physiol. 296: F10-F24 (2009). *

• Butterworth RF. Pathophysiology of hepatic encephalopathy: the concept of synergism. Hepatol. Res. 38 (s1: The 6 Japan Society of Hepatology Single Topic Conference: Liver Failure: Recent Progress and Pathogenesis to Management. 28-29 September 2007, Iwate, Japan): S116-S121 (2008). *

• Butterworth RF. Molecular neurobiology of acute liver failure. Semin. Liver Dis. 23: 251-258 (2003).

• Cao D, Li M, Xue R, Zheng W, Liu Z, Wang X. Chronic administration of ethyl docosahexaenoate decreases mortality and cerebral edema in ischemic gerbils. Life Sci. 78: 74-81 (2005). *

• Caparroz-Assef SM, Bersani-Amado CA, Kelmer-Bracht AM, Bracht A, Ishii-Iwamoto EL. The metabolic changes caused by dexamethasone in the adjuvant-induced arthritic rat. Mol. Cell. Biochem. 302: 87-98 (2007). *

• Caproni M, Volpi W, Giomi B, Cardinali C, Antiga E, Melani L, Dagata A, Fabbri P. Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm. Venereol. 84: 288-290 (2004).

• Cardenas A, Gines P. Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis. Semin. Nephrol. 21: 308-316 (2001).

• Cardoso CR, Provinciatto PR, Godoi DF, Vieira TS, Ferreira BR, Teixeira G, Rossi MA, Cunha FQ, Silva JS. B cells are involved in the modulation of pathogenic gut immune response in food-allergic enteropathy. Clin. Exp. Immunol. 154: 153-161 (2008). *

• Cardoso CR, Teixeira G, Provinciatto PR, Godoi DF, Ferreira BR, Milanezi CM, Ferraz DB, Rossi MA, Cunha FQ, Silva JS. Modulation of mucosal immunity in a murine model of food-induced intestinal inflammation. Clin. Exp. Allergy 38: 338-349 (2008). *

• Carlo JT, Demarco D, Smith BA, Livingston S, Wiser K, Kuhn JA, Lamont JP. The utility of capsule endoscopy and its role for diagnosing pathology in the gastrointestinal tract. Am. J. Surg. 190: 886-890 (2006). *

• Caye-Thomasen P, Nielsen TR, Petri NE. Primary oral manifestation of Crohn disease. Ugeskr. Laeger. 164: 3363-3364 (2002).

• Celinski K, Madro A, Prozorow-Krol B, Korolczuk A, Cichoz-Lach H, Slomka M, Korobowicz E. Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPAR-gamma)-specific agonist, as a modulator in experimental acute pancreatitis. Med. Sci. Monit. 15: BR21-BR29 (2009). *

• Cep LF, Carvalho LI, Carvalho LL, Almeida M, Budaruiche JS. Juvenile dermatomyositis presenting with anasarca a possible new variant. Acta Reumatol. Port. 33: 238-242 (2008).

• Chaby G, Viseux V, Poulain JF, De Cagny B, Denoeux JP, Lok C. Topical silver sulfadiazine-induced acute renal failure. Ann. Dermatol. Venereol. 132: 891-893 (2005).

• Chaimovitz C, Rochman J, Eidelman S, Better OS. Exaggerated natriuretic response to volume expansion in patients with primary biliary cirrhosis. Am. J. Med. Sci. 274: 173-178 (1977).

• Chan CW, Carpenter JR, Rigamonti C, Gunsar F, Burroughs AK. Survival following the development of ascites and/or oedema in primary biliary cirrhosis: a stage prognostic model. Gut 53: A84 (2004).

• Chan CW, Carpenter JR, Rigamonti C, Gunsar F, Burroughs AK. Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: a staged prognostic model. Scand. J. Gastroenterol. 40: 1081-1089 (2005). *

• Chan CW, Tsochatzis EA, Carpenter JR, Rigamonti C, Gunsar F, Burroughs AK. Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach. Aliment. Pharmacol. Ther. 31: 573-582 (2010). *

• Chandalia A, Clarke HJ, Clemens LE, Pandey B, Vicena V, Lee P, Lavan BE, Gregoire FM. MBX-102/JNJ39659100, a novel non-TZD selective partial PPAR-gamma agonist lowers triglyceride independently of PPAR-alpha activation. PPAR Res. 2009: 706852 (2009). *

• Chandrakasan S, Singh S, Ratho RK, Kumar S, Mishra B. Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis. Rheumatol. Int. 29: 565-567 (2009). *

• Chang SW, Ohara N. Increased pulmonary vascular permeability in rats with biliary cirrhosis: role of thromboxane A2. Am. J. Physiol. 264: L245-L252 (1993).

• Chavarria L, Oria M, Romero J, Alonso J, Lope-Piedrafita S, Cordoba J. Diffusion tensor imaging supports the cytotoxic origin of brain edema in a rat model of acute liver failure. Gastroenterology Oct 17 [Epub ahead of print] (2009). *

• Chen C, Xu S, Wang WX, Ding YM, Yu KH, Wang B, Chen XY. Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury. Arch. Med. Res. 40: 79-88 (2009).

• Chen CK, Wu HT, Chiou HJ, Wei CJ, Yen CH, Chang CY, Chen WM. Differentiating benign and malignant soft tissue masses by magnetic resonance imaging: role of tissue component analysis. J. Chin. Med. Assoc. 72: 194-201 (2009).

• Chen F, Ohashi N, Li W, Eckman C, Nguyen JH. Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology 50: 1914-1923 (2009).

• Chen G, Shi J, Hu Z, Hang C. Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine. Mediators Inflamm. 2008: 716458 (2008). *

• Chen JT, Collins DL, Atkins HL, Freedman MS, Galal A, Arnold DL. Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis. Neurology 66: 1935-1937 (2006).

• Chen X, Li SL, Wu T, Liu JD. Proteasome inhibitor ameliorates severe acute pancreatitis and associated lung injury of rats. World J. Gastroenterol. 14: 3249-3253 (2008). *

• Chen XR, Besson VC, Beziaud T, Plotkine M, Marchand-Leroux C. Combination therapy with fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, and simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on experimental traumatic brain injury. J. Pharmacol. Exp. Ther. 326: 966-974 (2008). *

• Chen Y, Chong MM, Darwiche R, Thomas HE, Kay TW. Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency. Am. J. Pathol. 165: 913-921 (2004). *

• Cheng F, Li Y, Feng L, Li S. Effects of tetrandrine on ischemia/reperfusion injury in mouse liver. Transplant. Proc. 40: 2163-2166 (2008). *

• Chillingworth NL, Morham SG, Donaldson LF. Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R327-334 (2006). *

• Ching DW, McClintock A, Beswick F. Successful treatment with low-dose thalidomide in a patient with both Behcet's disease and complex regional pain syndrome type I: case report. J. Clin. Rheumatol. 9: 96-98 (2003).

• Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease. BMC Gastroenterol. 5: 27 (2005). *

• Cimmino MA. Does magnetic resonance represent the gold-standard of imaging for the follow-up of arthritis? Reumatismo 58: 245-252 (2006).

• Cimmino MA, Parodi M, Zampogna G, Paparo F, Silvestri E, Garlaschi G, Scarpa R. Magnetic resonance imaging of the hand in psoriatic arthritis. J. Rheumatol. Suppl. 83: 39-41 (2009).

• Civilibal M, Canpolat N, Yurt A, Kurugoglu S, Erdamar S, Bagci O, Sever L, Kasapcopur O, Caliskan S, Arisoy N. A child with primary Sjogren syndrome and a review of the literature. Clin. Pediatr. (Phila.) 46: 738-742 (2007).

• Classen M, Gotze H, Richter HJ, Bender S. Primary sclerosing cholangitis in children. J. Pediatr. Gastroenterol. Nutr. 6: 197-202 (1987).

• Coates LC, Anderson RR, Fitzgerald O, Gottlieb AB, Kelly SG, Lubrano E, McGonagle DG, Olivieri I, Ritchlin CT, Tan AL, De Vlam K, Helliwell PS. Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review. J. Rheumatol. 35: 1438-1442 (2008).

• Cogan E. When thinking to scleroderma? Rev. Med. Brux. 28: 285-289 (2007).

• Cohly HH, Panja A. Immunological findings in autism. Int. Rev. Neurobiol. 71: 317-341 (2005).

• Cohran VC, Heubi JE. Treatment of pediatric cholestatic liver disease. Curr. Treat. Options Gastroenterol. 6: 403-415 (2003).

• Colombo C, Crosignani A, Apostolo MG, Marzano MT, Bettinardi N, Giunta A. Oral bile acids in cystic fibrosis-associated liver disease. J. R. Soc. Med. 87 Suppl. 21: 20-24 (1994). *

• Colombo G, Yacoub MR, Burastero SE, Garattini E, Girlanda S, Saporiti N, Salvo F, Sabbadini MG. Multiple drug hypersensivity: insight into the underlying mechanism and correlation with autoimmune diseases. Eur. Ann. Allergy Clin. Immunol. 41: 50-55 (2009).

• Connolly AK, Price SC, Connelly JC, Hinton RH. Early changes in bile duct lining cells and hepatocytes in rats treated with alpha-naphthylisothiocyanate. Toxicol. Appl. Pharmacol. 93: 208-219 (1988).

• Conte FD, Barja-Fidalgo C, Verri WA Jr, Cunha FQ, Rae GA, Penido C, Henriques MD. Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1. J. Leukoc. Biol. 84: 652-660 (2008). *

• Copeland BH, Aramide O, Wehbe S, Fitzgerald SM, Krishnaswamy G. Eosinophilia in a patient with cyclical vomiting: a case report. Clin. Mol. Allergy 2: 7 (2004). *

• Costa C, Sambataro A, Baldi S, Modena V, Todros L, Libertucci D, Coni F, Fusaro E, Revello F, Murgia A, et al. Primary biliary cirrhosis: lung involvement. Liver 15: 196-201 (1995).

• Cottrell GS, Amadesi S, Pikios S, Camerer E, Willardsen JA, Murphy BR, Caughey GH, Wolters PJ, Coughlin SR, Peterson A, Knecht W, Pothoulakis C, Bunnett NW, Grady EF. Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis. Gastroenterology 132: 2422-2437 (2007). *

• Cowden JM, Zhang M, Dunford PJ, Thurmond RL. The histamine H(4) receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J. Invest. Dermatol. Nov 12 [Epub ahead of print] (2009). *

• Craig DG, Lee A, Hayes PC, Simpson KJ. Review article: the current management of acute liver failure. Aliment. Pharmacol. Ther. 31: 345-358 (2010). *

• Cribier B. Psoriasis under the microscope. J. Eur. Acad. Dermatol. Venereol. 20 Suppl. 2: 3-9 (2006).

• Crippin JS, Gross JB Jr, Lindor KD. Increased intracranial pressure and hepatic encephalopathy in chronic liver disease. Am. J. Gastroenterol. 87: 879-882 (1992).

• Crisponi L, Crisponi G, Meloni A, Toliat MR, Nurnberg G, Usala G, Uda M, Masala M, Hohne W, Becker C, Marongiu M, Chiappe F, Kleta R, Rauch A, Wollnik B, Strasser F, Reese T, Jakobs C, Kurlemann G, Cao A, Nurnberg P, Rutsch F. Crisponi syndrome is caused by mutations in the CRLF1 gene and is allelic to cold-induced sweating syndrome type 1. Am. J. Hum. Genet. 80: 971-981 (2007). *

• Crone CC, Gabriel GM. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations. Clin. Pharmacokinet. 43: 361-394 (2004).

• Crowe JP, Christensen E, Butler J, Wheeler P, Doniach D, Keenan J, Williams R. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 78: 1437-1441 (1980).

• Cugno M, Castelli R, Cicardi M. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation. Autoimmun. Rev. 8: 156-159 (2008).

• Cugno M, Marzano AV, Asero R, Tedeschi A. Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications. Intern. Emerg. Med. Dec 1 [Epub ahead of print] (2009).

• Cukovic-Cavka S. Diffuse jejunoileitis in an adolescent. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 69. May 7-8 (2004). *

• Cuzzocrea S, Mazzon E, Di Paola R, Peli A, Bonato A, Britti D, Genovese T, Mui C, Crisafulli C, Caputi AP. The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation. J. Leukoc. Biol. 79: 999-1010 (2006). *

• Cuzzocrea S, Saadat F, Di Paola R, Mirshafiey A. Artemether: a new therapeutic strategy in experimental rheumatoid arthritis. Immunopharmacol. Immunotoxicol. 27: 615-630 (2005).

• D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E, Mattace Raso G, Cuzzocrea S, Lo Verme J, Piomelli D, Meli R, Calignano A. Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous PPAR-alpha agonist, modulates carrageenan-induced paw edema in mice. J. Pharmacol. Exp. Ther. 322: 1137-1143 (2007). *

• d'Almeida M, Jose J, Oneto J, Restrepo R. Bowel wall thickening in children: CT findings. Radiographics 28: 727-746 (2008). *

• Dagenais A, Boncoeur E, Berthiaume Y. Na+ transport in the lungs: differential impact of ENaC in the airways and alveoli. Med. Sci. (Paris) 25: 815-820 (2009).

• Dahlhoff M, Algul H, Siveke JT, Lesina M, Wanke R, Wartmann T, Halangk W, Schmid RM, Wolf E, Schneider MR. Betacellulin protects from pancreatitis by activating SAPK. Gastroenterology Dec 25 [Epub ahead of print] (2009). *

• Dang S, Sigal Y, Davies D. Recurrent cellulitis in a case of Aagenaes syndrome. Clin. Pediatr. (Phila.) 48: 873-874 (2009).

• Das SK, Chakrabarti R. Role of PPAR in cardiovascular diseases. Recent Patents Cardiovasc. Drug Discov. 1: 193-209 (2006).

• de Bruin EC, van de Pas S, van de Velde CJ, van Krieken JH, Peltenburg LT, Marijnen CA, Medema JP. Gene expression profiling reveals two separate mechanisms regulating apoptosis in rectal carcinomas in vivo. Apoptosis 12: 1671-1680 (2007). *

• de Carvalho JF, Shoenfeld Y. Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination. Eur. J. Intern. Med. 19: 383-385 (2008).

• De Hertogh G, Geboes K. Crohn's disease and infections: a complex relationship. MedGenMed. 6: 14 (2004). *

• De Lange T, Larsen S, Aabakken L. Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis. BMC Gastroenterol. 4: 9 (2004). *

• de Man RA. Severe hepatitis attributed to paroxetine (Seroxat). Ned. Tijdschr. Geneeskd. 141: 540-542 (1997).

• De Quatrebarbes J, Cordel N, Bravard P, Lenormand B, Joly P. Miescher's cheilitis and lymphocytic clonal expansion: 2 cases. Ann. Dermatol. Venereol. 131: 55-57 (2004).

• Declue AE, Williams KJ, Sharp C, Haak C, Lechner E, Reinero CR. Systemic response to low-dose endotoxin infusion in cats. Vet. Immunol. Immunopathol. 132: 167-174 (2009).

• Degner D, Grohmann R, Kropp S, Ruther E, Bender S, Engel RR, Schmidt LG. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 37 Suppl. 1: S39-S45 (2004).

• Deguchi Y, Andoh A, Inatomi O, Araki Y, Hata K, Tsujikawa T, Kitoh K, Fujiyama Y. Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5. Int. J. Mol. Med. 16: 605-608 (2005).

• Denk H. Pathology of portal hypertension. J. Gastroenterol. Hepatol. 19: S346-S348 (2004). *

• Der G, Love T, Schreck J, Horn M. Primary sclerosing cholangitis: a case presentation. Gastroenterol. Nurs. 28: 13-16 (2005). *

• Deshpande V, Hsu M, Kumarasinghe MP, Lauwers GY. The clinical significance of incidental chronic colitis: a study of 17 cases. Am. J. Surg. Pathol. Feb 11 [Epub ahead of print] (2010).

• Dessimoz J, Bonnard C, Huelsken J, Grapin-Botton A. Pancreas-specific deletion of beta-catenin reveals Wnt-dependent and Wnt-independent functions during development. Curr. Biol. 15: 1677-1683 (2005). *

• Devitt G, Meyer C, Wiedemann N, Eichmuller S, Kopp-Schneider A, Haferkamp A, Hautmann R, Zoller M. Serological analysis of human renal cell carcinoma. Int. J. Cancer 118: 2210-2219 (2006). *

• Di Lorenzo G, Pacor ML, Mansueto P, Esposito-Pellitteri M, Ditta V, Lo Bianco C, Leto-Barone MS, Di Fede G, Rini GB. Is there a role for antileukotrienes in urticaria? Clin. Exp. Dermatol. 31: 327-334 (2006).

• di Meglio P, Ianaro A, Ghosh S. Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation. Arthritis Rheum. 52: 951-958 (2005). *

• Dia D, Ba-Fall K, Bouldouyre M, Chevalier B, Debonne JM. DRESS syndrome to allopurinol: a case in Dakar. Dakar Med. 49: 114-115 (2004).

• Diaz-Llopis M, Garcia-Delpech S, Salom D, Udaondo P, Hernandez-Garfella M, Bosch-Morell F, Quijada A, Romero FJ. Adalimumab therapy for refractory uveitis: a pilot study. J. Ocul. Pharmacol. Ther. 24: 351-361 (2008).

• Diaz-Viciedo R, Hortelano S, Giron N, Masso JM, Rodriguez B, Villar A, de Las Heras B. Modulation of inflammatory responses by diterpene acids from Helianthus annuus L. Biochem. Biophys. Res. Commun. 369: 761-766 (2008). *

• Dice JP. Physical urticaria. Immunol. Allergy Clin. North Am. 24: 225-246, vi (2004).

• Dienes HP. Histopathology of overlap syndromes in the liver. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 44-45. October 15-16 (2003). *

• DiIulio NA, Xu H, Fairchild RL. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response. Eur. J. Immunol. 26: 2606-2612 (1996).

• DiMagno MJ, Lee SH, Hao Y, Zhou Sy, McKenna BJ, Owyang C. A proinflammatory, anti-apoptotic phenotype underlies the susceptibility to acute pancreatitis in UNC cftr (-/-) mice. Gastroenterology 129: 665-681 (2005). *

• Ding YJ, Yu JP, Luo HS, Zhou ZY, Liu J. Evaluation and analysis of colonoscopy in the diagnosis of 186 cases of ulcerative colitis patients. Int. J. Clin. Pract. 60: 1408-1410 (2006). *

• Djuric Z, Kamenov B, Katic V. Celiac disease manifested by polyneuropathy and swollen ankles. World J. Gastroenterol. 13: 2636-2638 (2007). *

• Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia SH, Headon DJ, Overbeek PA, Le Deist F, Holland SM, Belani K, Kumararatne DS, Fischer A, Shapiro R, Conley ME, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat. Genet. 27: 277-285 (2001). *

• Dohn UM, Skjodt H, Hetland ML, Vestergaard A, Moller JM, Knudsen LS, Ejbjerg BJ, Thomsen HS, Ostergaard M. No erosive progression revealed by MRI in rheumatoid arthritis patients treated with etanercept, even in patients with persistent MRI and clinical signs of joint inflammation. Clin. Rheumatol. 26: 1857-1861(2007). *

• Dotan I, Hallak A, Arber N, Santo M, Alexandrowitz A, Knaani Y, Hershkoviz R, Brazowski E, Halpern Z. Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial. Dig. Dis. Sci. 46: 2239-2244 (2001). *

• Dragon-Durey MA, Fremeaux-Bacchi V. Complement component deficiencies in human disease. Presse. Med. 35: 861-870 (2006).

• Dreyfus DH. Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema. Ann. Allergy Asthma Immunol. 100: 624-625 (2008).

• Drivdal M, Trydal T, Hagve TA, Bergstad I, Aagenaes O. Prognosis, with evaluation of general biochemistry, of liver disease in lymphoedema cholestasis syndrome 1 (LCS1/Aagenaes syndrome). Scand. J. Gastroenterol. 41: 465-471 (2006). *

• Dubois M, Vantyghem MC, Schoonjans K, Pattou F. Thiazolidinediones in type 2 diabetes. Role of peroxisome proliferator-activated receptor gamma (PPARgamma). Ann. Endocrinol. (Paris) 63: 511-523 (2002).

• Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, Gray M, D'Acquisto F, Buckingham JC, Perretti M, Flower RJ. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J. Immunol. Jan 27 [Epub ahead of print] (2010).

• Dusunceli E, Erden A, Erden I, Karayalcin S. Primary sclerosing cholangitis: MR cholangiopancreatography and T2-weighted MR imaging findings. Diagn. Interv. Radiol. 11: 213-218 (2005). *

• Ebner H, Mischer P. Vitamin A acid in lichen planus. Acta Derm. Venereol. Suppl. (Stockh.) 74: 161-162 (1975).

• Eckstein AK, Johnson KT, Thanos M, Esser J, Ludgate M. Current insights into the pathogenesis of Graves' orbitopathy. Horm. Metab. Res. 41: 456-464 (2009).

• Edelman DA, Jiang Y, Tyburski JG, Wilson RF, Steffes CP. Cytokine production in lipopolysaccharide-exposed rat lung pericytes. J. Trauma 62: 89-93 (2007).

• Efthymiou A, Viazis N, Mantzaris G, Papadimitriou N, Tzourmakliotis D, Raptis S, Karamanolis DG. Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy. Inflamm. Bowel Dis. 14: 1542-1547 (2008). *

• Egetenmeier H, Lang GE. Papilledema in Crohn's disease. Klin. Monatsbl. Augenheilkd. 224: 943-944 (2007).

• Eisenhut M. Changes in ion transport in inflammatory disease. J. Inflamm. (Lond.) 3: 5 (2006). *

• Ekstrom GM, Andersson SE. Plasma exudation, hyperaemia, and epithelial permeability in rats with oxazolone-induced colitis: modulatory effects of budesonide. Scand. J. Gastroenterol. 35: 190-197 (2000). *

• Elias E. Hepatology highlights. Hepatology 39: 1467-1468 (2004). *

• Ellsworth JL, Maurer M, Harder B, Hamacher N, Lantry M, Lewis KB, Rene S, Byrnes-Blake K, Underwood S, Waggie KS, Visich J, Lewis KE. Targeting immune complex-mediated hypersensitivity with recombinant soluble human FcgammaRIA (CD64A). J. Immunol. 180: 580-589 (2008). *

• Elseweidy MM, Younis NN, Amin RS, Abdallah FR, Fathy AM, Yousif ZA. Effect of some natural products either alone or in combination on gastritis induced in experimental rats. Dig. Dis. Sci. 53: 1774-1784 (2008). *

• Engelhardt B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J. Neural. Transm. 113: 477-485 (2006). *

• Engelhardt B, Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin. Immunopathol. Sep 25 [Epub ahead of print] (2009). *

• Erkan G, Alagozlu H, Memis L, Tuncer C. Rapidly growing giant solitary cavernous hemangioma in a patient with ulcerative colitis. Turk. J. Gastroenterol. 19: 271-275 (2008). *

• Escandell JM, Recio MC, Giner RM, Manez S, Cerda-Nicolas M, Merfort I, Rios JL. Inhibition of delayed-type hypersensitivity by cucurbitacin R through the curbing of lymphocyte proliferation and cytokine expression by means of NFAT translocation to the nucleus. J. Pharmacol. Exp. Ther. Oct 21 [Epub ahead of print] (2009). *

• Esposito I, Kubisova A, Stiehl A, Kulaksiz H, Schirmacher P. Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis. Virchows Arch. 453: 339-345 (2008). *

• Estrin HM, Hughes RW Jr. Oral manifestations in Crohn's disease: report of a case. Am. J. Gastroenterol. 80: 352-354 (1985).

• Farah R, Lisitsin S, Shay M. Bacterial meningitis associated with infliximab. Pharm. World Sci. 28: 123-125 (2006).

• Fasano MB. Dermatologic food allergy. Pediatr. Ann. 35: 727-731 (2006).

• Fauchald P, Ritland S. Interstitial fluid volume, plasma volume and transcapillary colloid osmotic gradient in patients with hepatic cirrhosis and fluid retention. Scand. J. Clin. Lab. Invest. 45: 553-559 (1985).

• Fernandez Hermida RV, Pinar S, Muruzabal N. Clinical manifestations of thyroid ophthalmopathy. An. Sist. Sanit. Navar. 31 Suppl. 3: 45-56 (2008).

• Ferrandi C, Ardissone V, Ferro P, Ruckle T, Zaratin P, Ammannati E, Hauben E, Rommel C, Cirillo R. Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J. Pharmacol. Exp. Ther. 322: 923-930 (2007). *

• Ferrante M, Penninckx F, De Hertogh G, Geboes K, D'Hoore A, Noman M, Vermeire S, Rutgeerts P, Van Assche G. Protein-losing enteropathy in Crohn's disease. Acta Gastroenterol. Belg. 69: 384-389 (2006).

• Ferrer M. Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. Alergologica 2005. J. Investig. Allergol. Clin. Immunol 19 Suppl. 2: 21-26 (2009).

• Ferreyra HA, Jayasundera T, Khan NW, He S, Lu Y, Heckenlively JR. Management of autoimmune retinopathies with immunosuppression. Arch. Ophthalmol. 127: 390-397 (2009). *

• Ferris I Tortajada J, Ortega Garcia JA, Garcia I Castell J, Lopez Andreu JA, Ribes Koninckx C, Berbel Tornero O. Risks factors for pediatric malignant liver tumors. An. Pediatr. (Barc.) 68: 377-384 (2008).

• Fidder HH, Nadler M, Lahat A, Lahav M, Bardan E, Avidan B, Bar-Meir S. The utility of capsule endoscopy in the diagnosis of Crohn's disease based on patient's symptoms. J. Clin. Gastroenterol. 41: 384-387 (2007).

• Firmin D, Roguedas AM, Lemasson G, Abgrall JF, Misery L. Eczematous dermatosis and thrombocytosis induced by efalizumab: two new side effects. Dermatology 217: 203-206 (2008).

• Folch-Puy E, Granell S, Iovanna JL, Barthet M, Closa D. Peroxisome proliferator-activated receptor gamma agonist reduces the severity of post-ERCP pancreatitis in rats. World J. Gastroenterol. 12: 6458-6463 (2006). *

• Fonacier LS, Dreskin SC, Leung DY. Allergic skin diseases. J. Allergy Clin. Immunol. Nov 23 [Epub ahead of print] (2009). *

• Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee SS. Prediction of cardiac complications after liver transplantation. Transplantation 87: 763-770 (2009).

• Franco J, Saeian K. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis. Curr. Gastroenterol. Rep. 1: 95-101 (1999).

• Frey FJ. Impaired 11beta-hydroxysteroid dehydrogenase contributes to renal sodium avidity in cirrhosis: hypothesis or fact? Hepatology 44: 795-801 (2006). *

• Fruhwirth M, Janecke AR, Muller T, Carlton VE, Kronenberg F, Offner F, Knisely AS, Geleff S, Song EJ, Simma B, Konigsrainer A, Margreiter R, van der Hagen CB, Eiklid K, Aagenaes O, Bull L, Ellemunter H. Evidence for genetic heterogeneity in lymphedema-cholestasis syndrome. J. Pediatr. 142: 441-447 (2003). *

• Fujii K, Miyashita T, Omata T, Kobayashi K, Takanashi J, Kouchi K, Yamada M, Kohno Y. Gorlin syndrome with ulcerative colitis in a Japanese girl. Am. J. Med. Genet. A. 121A: 65-68 (2003).

• Fujisawa A, Kambe N, Saito M, Nishikomori R, Tanizaki H, Kanazawa N, Adachi S, Heike T, Sagara J, Suda T, Nakahata T, Miyachi Y. Disease-associated mutations in CIAS1 induce cathepsin B-dependent rapid cell death of human THP-1 monocytic cells. Blood 109: 2903-2911 (2007). *

• Fustik S, Jacovska T, Spirevska L, Koceva S. Protein-energy malnutrition as first manifestation of cystic fibrosis in infancy. Pediatr. Int. 51: 678-683 (2009). *

• Gambichler T, Reich S, Banasch M, Altmeyer P. Complex extra-intestinal complications of ulcerative colitis in a patient with alpha1-antitrypsin deficiency. Eur. J. Med. Res. 11: 135-138 (2006).

• Gani OA. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists? Cardiovasc. Diabetol. 7: 6 (2008). *

• Garcia-Careaga M Jr, Kerner JA Jr. Gastrointestinal manifestations of food allergies in pediatric patients. Nutr. Clin. Pract. 20: 526-535 (2005). *

• Garg K, Lynch DA, Newell JD. Inflammatory airways disease in ulcerative colitis: CT and high-resolution CT features. J. Thorac. Imaging 8: 159-163 (1993).

• Geese WJ, Achanzar W, Rubin C, Hariharan N, Cheng P, Tomlinson L, Ordway N, Dracopoli NC, Delmonte T, Hui L, Krishnan B, Cosma G, Ranade K. Genetic and gene expression studies implicate renin and endothelin-1 in edema caused by peroxisome proliferator-activated receptor gamma agonists. Pharmacogenet. Genomics 18: 903-910 (2008).

• Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Bramanti P, Piomeli D, Calignano A, Cuzzocrea S. Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J. Pharmacol. Exp. Ther. 326: 12-23 (2008). *

• Genovese T, Mazzon E, Di Paola R, Muia C, Crisafulli C, Malleo G, Esposito E, Cuzzocrea S. Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein. Immunology 118: 559-570 (2006). *

• German AC, Myint KS, Mai NT, Pomeroy I, Phu NH, Tzartos J, Winter P, Collett J, Farrar J, Barrett A, Kipar A, Esiri MM, Solomon T. A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans. R. Soc. Trop. Med. Hyg. 100: 1135-1145 (2006). *

• Gershwin ME, Incaudo G. Topics in allergy and immunology during pregnancy and early infancy. Clin. Rev. Allergy Immunol. 26: 127-128 (2004).

• Gheith O, Al-Otaibi T, Tawab KA, Said T, Balaha MA, Halim MA, Nair MP, Nampoory MR. Erythema nodosum in renal transplant recipients: multiple cases and review of literature. Transpl. Infect. Dis. Dec 14 [Epub ahead of print] (2009).

• Gianoukakis AG, Jennings TA, King CS, Sheehan CE, Hoa N, Heldin P, Smith TJ. Hyaluronan accumulation in thyroid tissue: evidence for contributions from epithelial cells and fibroblasts. Endocrinology 148: 54-62 (2007). *

• Giavina-Bianchi P, Silva Fde S, Toledo-Barros M, Birolini D, Kalil J, Rizzo LV. A rare intestinal manifestation in a patient with common variable immunodeficiency and strongyloidiasis. Int. Arch. Allergy Immunol. 140: 199-204 (2006).

• Girlanda R, Vilca-Melendez H, Srinivasan P, Muiesan P, O'Grady JG, Rela M, Heaton ND. Immunosuppression withdrawal after auxiliary liver transplantation for acute liver failure. Transplant. Proc. 37: 1720-1721 (2005). *

• Girszyn N, Leport J, Arnaud L, Kahn JE, Piette AM, Bletry O. Crohn's disease affecting only vulvoperineal area. Presse. Med. 36: 1762-1765 (2007).

• Gislason D, Bjoernsson E, Gislason T. Allergy and intolerance to food in an Icelandic urban population 20-44 years of age. Laeknabladid. 86: 851-857 (2000).

• Goke B, Gause-Nilsson I, Persson A; On Behalf Of The Gallant 8 Study Group. The effects of tesaglitazar as add-on treatment to metformin in patients with poorly controlled type 2 diabetes. Diab. Vasc. Dis. Res. 4: 204-213 (2007).

• Goldberg Green M, Bragg J, Rosenman KS, Keltz Pomeranz M. Pustular psoriasis of pregnancy in a patient whose dermatosis showed features of acute generalized exanthematous pustulosis. Int. J. Dermatol. 48: 299-303 (2009).

• Goldstein MF, Goldstein AL, Dunsky EH, Dvorin DJ, Belecanech GA, Shamir K. Selective IgM immunodeficiency: retrospective analysis of 36 adult patients with review of the literature. Ann. Allergy Asthma Immunol. 97: 717-730 (2006).

• Goldstein N, Dulai M. Contemporary morphologic definition of backwash ileitis in ulcerative colitis and features that distinguish it from Crohn disease. Am. J. Clin. Pathol. 126: 1-12 (2006). *

• Goldstein NS. Isolated ileal erosions in patients with mildly altered bowel habits. A follow-up study of 28 patients. Am. J. Clin. Pathol. 125: 838-846 (2006).

• Golofeevsky VY. Histological evaluation of activity of the ulcerative colitis in its initial stage of development. Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, p. 42 (2006). *

• Gomes Mde B. Glitazones and the metabolic syndrome: mechanism of action, pathophysiology and therapeutic indications. Arq. Bras. Endocrinol. Metabol. 50: 271-280 (2006).

• Goncalves DU, de Castro MM, Galvao CP, Brandao AZ, de Castro MC, Lambertucci JR. Cheilitis granulomatosa associated with Melkersson-Rosenthal syndrome. Rev. Bras. Otorrinolaringol. (Engl. Ed.) 73: 132-133 (2007). *

• Gotua M, Lomidze N, Dolidze N, Gotua T. IgE-mediated food hypersensitivity disorders. Georgian Med. News 157: 39-44 (2008).

• Grabbe S, Varga G, Beissert S, Steinert M, Pendl G, Seeliger S, Bloch W, Peters T, Schwarz T, Sunderkotter C, Scharffetter-Kochanek K. Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells. J. Clin. Invest. 109: 183-192 (2002). *

• Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety. CNS Drugs 23: 397-418 (2009).

• Granel B, Philip N, Serratrice J, Ene N, Grateau G, Dode C, Cuisset L, Disdier P, Berbis P, Delpech M, Weiller PJ. CIAS1 mutation in a patient with overlap between Muckle-Wells and chronic infantile neurological cutaneous and articular syndromes. Dermatology 206: 257-259 (2003).

• Grassl GA, Valdez Y, Bergstrom KS, Vallance BA, Finlay BB. Chronic enteric Salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology 134: 768-780.e2 (2008). *

• Gregoriou S, Rigopoulos D, Katsambas A, Katsarou A, Papaioannou D, Gkouvi A, Kontochristopoulos G, Danopoulou I, Stavrianeas N, Kalogeromitros D. Etiologic aspects and prognostic factors of patients with chronic urticaria: nonrandomized, prospective, descriptive study. J. Cutan. Med. Surg. 13: 198-203 (2009).

• Gressier L, Pruvost-Balland C, Dubertret L, Viguier M. Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS). Ann. Dermatol. Venereol. 136: 50-53 (2009).

• Griesbacher T, Pommer V, Schuligoi R, Tiran B, Peskar BA. Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis. Int. Immunopharmacol. 8: 325-329 (2008).

• Grijm R, Huibregtse K, Bartelsman J, Mathus-Vliegen EM, Dekker W, Tytgat GN. Therapeutic investigations in primary sclerosing cholangitis. Dig. Dis. Sci. 31: 792-798 (1986).

• Gropman AL, Adams DR. Atypical patterns of inheritance. Semin. Pediatr. Neurol. 14: 34-45 (2007).

• Grossetete M, Rosenberg GA. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse. J. Cereb. Blood Flow Metab. 28: 752-763 (2008).

• Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, Ubiali E, Amodio P; members of the ISHEN commission on Neurophysiological Investigations. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 29: 789-796 (2009). *

• Guilford WJ, Parkinson JF. Second-generation beta-oxidation resistant 3-oxa-lipoxin A(4) analogs. Prostaglandins Leukot. Essent. Fatty Acids 73: 245-250 (2005). *

• Gulben K, Ozdemir H, Berberoglu U, Mersin H, Yrkin F, Cakyr E, Aksaray S. Melatonin modulates the severity of taurocholate-induced acute pancreatitis in the rat. Dig. Dis. Sci. Apr 28 [Epub ahead of print] (2009). *

• Gulec M, Caliskaner Z, Tunca Y, Ozturk S, Bozoglu E, Gul D, Erel F, Kartal O, Karaayvaz M. The role of ACE gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. Allergol. Immunopathol. (Madr.) 36: 134-140 (2008).

• Gulubova MV, Manolova IM, Vlaykova TI, Prodanova M, Jovchev JP. Adhesion molecules in chronic ulcerative colitis. Int. J. Colorectal Dis. 22: 581-589 (2007). *

• Gumbs AA, Kim J, Kiehna E, Brink JA, Salem RR. Autoimmune pancreatitis presenting as simultaneous masses in the pancreatic head and gallbladder. JOP 6: 455-459 (2005). *

• Guo RF, Riedemann NC, Ward PA. Role of C5a-C5aR interaction in sepsis. Shock 21: 1-7 (2004). *

• Gurkan S, Dikman S, Saland MJ. A case of autoimmune thyroiditis and membranoproliferative glomerulonephritis. Pediatr. Nephrol. 24: 193-197 (2009).

• Haavardsholm EA, Boyesen P, Ostergaard M, Schildvold A, Kvien TK. Magnetic resonance imaging findings in 84 early rheumatoid arthritis patients: bone marrow edema predicts erosive progression. Ann. Rheum. Dis. 67: 794-800 (2008).

• Haavardsholm EA, Ostergaard M, Hammer HB, Boyesen P, Boonen A, van der Heijde D, Kvien TK. Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist compared to conventional measures of disease activity and structural damage. Ann. Rheum. Dis. 68: 1572-1579 (2009).

• Hadj Kacem H, Rebai A, Kaffel N, Masmoudi S, Abid M, Ayadi H. PDS is a new susceptibility gene to autoimmune thyroid diseases: association and linkage study. J. Clin. Endocrinol. Metab. 88: 2274-2280 (2003). *

• Hadj-Kacem H, Rebuffat S, Mnif-Feki M, Belguith-Maalej S, Ayadi H, Peraldi-Roux S. Autoimmune thyroid diseases: genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions. Int. J. Immunogenet. 36: 85-96 (2009). *

• Hagar HH, El Medany A, El Eter E, Arafa M. Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats. Eur. J. Pharmacol. 554: 69-77 (2007).

• Halim MA, Said T, Nair P, Schmidt I, Hassan A, Johny KV, Al-Muzairai I, Samhan M, Nampoory MR, Al-Mousawi M. De novo Crohn's disease in a renal transplant recipient. Transplant. Proc. 39: 1278-1279 (2007). *

• Hamblin TJ. Non-hemic autoimmunity in CLL. Leuk. Res. 33: 366-367 (2009).

• Han PD, Cohen RD. Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease. Drugs 64: 1767-1777 (2004).

• Hanif M, Raza J, Qureshi H, Issani Z. Etiology of chronic liver disease in children. J. Pak. Med. Assoc. 54: 119-122 (2004).

• Hansen L, Ekstrom CT, Palacios RT, Anant M, Wassermann K, Reinhardt RR. The Pro12Ala variant of the PPARG gene is a risk factor for PPARgamma/alpha agonist induced edema in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 91: 3446-3450 (2006). *

• Hardenberg G, Fernandez L, Hendriks J, Chebli K, Jacquet C, Sitbon M, Hahne M, Medema JP. APRIL facilitates viral-induced erythroleukemia but is dispensable for T cell immunity and lymphomagenesis. J. Leukoc. Biol. 84: 380-388 (2008). *

• Hardenberg G, Planelles L, Schwarte CM, van Bostelen L, Le Huong T, Hahne M, Medema JP. Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR-dependent manner. Eur. J. Immunol. 37: 2900-2911 (2007). *

• Hasegawa N, Ishimoto S, Takazoe M, Tsunoda K, Fujimaki Y, Shiraishi A, Kinoshita M, Okada K. Recurrent hoarseness due to inflammatory vocal fold lesions in a patient with Crohn's disease. Ann. Otol. Rhinol. Laryngol. 118: 532-535 (2009).

• Hattar K, Oppermann S, Ankele C, Weissmann N, Schermuly RT, Bohle RM, Moritz R, Krogel B, Seeger W, Grimminger F, Sibelius U, Grandel U. c-ANCA induce neutrophil-mediated lung injury - a model of acute Wegener's granulomatosis. Eur. Respir. J. Dec 23 [Epub ahead of print] (2009).

• Haussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 43: 1187-1190 (2006). *

• Haussinger D, Gorg B, Reinehr R, Schliess F. Protein tyrosine nitration in hyperammonemia and hepatic encephalopathy. Metab. Brain Dis. 20: 285-294 (2005).

• Haussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J. Hepatol. 32: 1035-1038 (2000). *

• Haussinger D, Schliess F, Kircheis G. Pathogenesis of hepatic encephalopathy. J. Gastroenterol. Hepatol. 17 Suppl. 3: S256-S259 (2002).

• Hayashi H, Shimizu K, Tani T, Takamura H, Takeshita M, Funaki K, Kitagawa H, Kayahara M, Ota T, Miwa K. Multiple organ failure caused by end-stage liver disease successfully treated with living donor liver transplantation using perioperative percutaneous cardiopulmonary support: a case report. Transplant. Proc. 37: 1101-1103 (2005).

• Healy PJ, Groves C, Chandramohan M, Helliwell PS. MRI changes in psoriatic dactylitis extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology (Oxford) 47: 92-95 (2008). *

• Heatley RV, Bolton PM, Owen E, Williams WJ, Hughes LE. A search for a transmissible agent in Crohn's disease. Gut 16: 528-532 (1975). *

• Heiligenhaus A, Niewerth M, Mingels A, Ganser G, Thon A, Pleyer U, Greiner K, Minden K. Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database. Klin. Monatsbl. Augenheilkd. 222: 993-1001 (2005).

• Helyes Z, Pinter E, Sandor K, Elekes K, Banvolgyi A, Keszthelyi D, Szoke E, Toth DM, Sandor Z, Kereskai L, Pozsgai G, Allen JP, Emson PC, Markovics A, Szolcsanyi J. Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice. Proc. Natl. Acad. Sci. U.S.A. 106: 13088-13093 (2009). *

• Henriksen NT, Drablos PA, Aagenaes O. Cholestatic jaundice in infancy. The importance of familial and genetic factors in aetiology and prognosis. Arch. Dis. Child. 56: 622-627 (1981).

• Henry RR, Lincoff AM, Mudaliar S, Rabbia M, Chognot C, Herz M. Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study. Lancet 374: 126-135 (2009). *

• Hetland ML, Ejbjerg BJ, Horslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Skjodt H, Pedersen JK, Majgaard O, Svendsen AJ, Ellingsen T, Lindegaard HM, et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2 year randomized controlled trial (CIMESTRA). Ann. Rheum. Dis. 68: 384-390 (2009).

• Higgins LS, Depaoli AM. Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation. Am. J. Clin. Nutr. 91: 267S-272S (2010). *

• Higgins PD, Fontana RJ. Liver transplantation in acute liver failure. Panminerva. Med. 45: 85-94 (2003).

• Hinson SR, McKeon A, Lennon VA. Neurological autoimmunity targeting aquaporin-4. Neuroscience Aug 19 [Epub ahead of print] (2009).

• Hinz S, Muller A, Machnik G, Franke H, Zimmermann T, Dargel R. Isolation and characterization of hepatocytes from chronic cholestatic damage to rat livers after bile duct ligation. Z. Gastroenterol. 31 Suppl. 2: 24-27 (1993).

• Hirai Y, Iyoda M, Shibata T, Ashikaga E, Hosaka N, Suzuki H, Nagai H, Mukai M, Honda H, Kuroki A, Kitazawa K, Akizawa T. Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia. Clin. Exp. Nephrol. 12: 393-397 (2008).

• Hirano K, Tada M, Isayama H, Yamamoto K, Mizuno S, Yagioka H, Yashima Y, Sasaki T, Kogure H, Togawa O, Arizumi T, Matsubara S, Nakai Y, Sasahira N, Tsujino T, Kawabe T, Omata M. Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis. Gastrointest. Endosc. Oct 15 [Epub ahead of print] (2009).

• Hiratani H, Akamizu T. Association study on candidate loci of susceptible genes of autoimmune thyroid diseases in a Japanese population. Rinsho Byori 49: 1151-1156 (2001).

• Hirche TO, Hirche H, Jungblut S, Stern M, Wagner TO, Wiedemann B; on behalf of the German CFQA Group. Statistical limitations of percent ideal body weight as measure for nutritional failure in patients with cystic fibrosis. J. Cyst. Fibros. 8: 238-244 (2009).

• Hirose W, Nishikawa K, Hirose M, Nanki T, Sugimoto H. Response of early active rheumatoid arthritis to tumor necrosis factor inhibitors: evaluation by magnetic resonance imaging. Mod. Rheumatol. 19: 20-26 (2009). *

• Hise AG, Hazlett FE, Bockarie MJ, Zimmerman PA, Tisch DJ, Kazura JW. Polymorphisms of innate immunity genes and susceptibility to lymphatic filariasis. Genes Immun. 4: 524-527 (2003). *

• Hobolth L, Bendtsen F. Cocain-triggered ischaemic enteritis. Ugeskr. Laeger. 171: 2748-2750 (2009).

• Hoedemaekers AC, van Breda Vriesman PJ, De Baets MH. Myasthenia gravis as a prototype autoimmune receptor disease. Immunol. Res. 16: 341-354 (1997).

• Hoffmann P, Reinshagen M, Zeeh JM, Lakshmanan J, Wu VS, Goebell H, Gerken G, Eysselein VE. Increased expression of epidermal growth factor-receptor in an experimental model of colitis in rats. Scand. J. Gastroenterol. 35: 1174-1180 (2000). *

• Holden NS, Gong W, King EM, Kaur M, Giembycz MA, Newton R. Potentiation of NF-kappaB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells. Br. J. Pharmacol. 152: 891-902 (2007). *

• Hollerweger A, Macheiner P, Dirks K, Dietrich CF. Differential diagnosis of severe hypoechoic oedema of the small bowel. Ultraschall. Med. 27: 234-239 (2006).

• Holtmeier W, Caspary WF. Celiac disease. Orphanet J. Rare Dis. 1: 3 (2006). *

• Horton KM, Lawler LP, Fishman EK. CT findings in sclerosing mesenteritis (panniculitis): spectrum of disease. Radiographics 23: 1561-1567 (2003). *

• Hosoyamada T. Clinical studies of pediatric malabsorption syndromes. Fukuoka Igaku Zasshi 97: 322-350 (2006).

• Hoth JJ, Hudson WP, Brownlee NA, Yoza BK, Hiltbold EM, Meredith JW, McCall CE. Toll-like receptor 2 participates in the response to lung injury in a murine model of pulmonary contusion. Shock 28: 447-452 (2007). *

• Hsieh CH, Frink M, Hsieh YC, Kan WH, Hsu JT, Schwacha MG, Choudhry MA, Chaudry IH. The role of MIP-1alpha in the development of systemic inflammatory response and organ injury following trauma hemorrhage. J. Immunol. 181: 2806-2812 (2008). *

• Huang GZ, Li L, Liu L. Pathological study on autopsy died of Tripterygium intoxication - report of 4 cases. Zhongguo Zhong Xi Yi Jie He Za Zhi 29: 165-168 (2009).

• Hubmacher D, Tiedemann K, Bartels R, Brinckmann J, Vollbrandt T, Batge B, Notbohm H, Reinhardt DP. Modification of the structure and function of fibrillin-1 by homocysteine suggests a potential pathogenetic mechanism in homocystinuria. J. Biol. Chem. 280: 34946-34955 (2005). *

• Hui T, Rozga J, Demetriou AA. Bioartificial liver support. J. Hepatobiliary Pancreat. Surg. 8: 1-15 (2001). *

• Humbert M, de Blay F, Garcia G, Prud'homme A, Leroyer C, Magnan A, Tunon-de-Lara JM, Pison C, Aubier M, Charpin D, Vachier I, Purohit A, Gineste P, Bader T, Moussy A, Hermine O, Chanez P. Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics. Allergy 64: 1194-1201 (2009).

• Hundsberger H, Verin A, Wiesner C, Pfluger M, Dulebo A, Schutt W, Lasters I, Mannel DN, Wendel A, Lucas R. TNF: a moonlighting protein at the interface between cancer and infection. Front. Biosci. 13: 5374-5386 (2008).

• Hyong A, Jadhav V, Lee S, Tong W, Rowe J, Zhang JH, Tang J. Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents. Brain Res. 1215: 218-224 (2008).

• Hyun E, Ramachandran R, Cenac N, Houle S, Rousset P, Saxena A, Liblau RS, Hollenberg MD, Vergnolle N. Insulin modulates protease-activated receptor 2 signaling: implications for the innate immune response. J. Immunol. Jan 29 [Epub ahead of print] (2010).

• Igarashi M, Hirata A, Yamaguchi H, Jimbu Y, Tominaga M. Pioglitazone reduces atherogenic outcomes in type 2 diabetic patients. J. Atheroscler. Thromb. 15: 34-40 (2008).

• Iida A, Inagaki K, Miyazaki A, Yonemori F, Ito E, Igarashi K. Bach1 deficiency ameliorates hepatic injury in a mouse model. Tohoku J. Exp. Med. 217: 223-229 (2009). *

• Ikeda S. Adult-onset citrullinemia. Brain Nerve 59: 59-66 (2007).

• Ilan Y, Weksler-Zangen S, Ben-Horin S, Diment J, Sauter B, Rabbani E, Engelhardt D, Chowdhury NR, Chowdhury JR, Goldin E. Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. Am. J. Gastroenterol. 95: 966-973 (2000). *

• Imamura K, Lu J, Kaminishi M. Roles of PPARs in carcinogenesis. Nippon Rinsho 63: 584-588 (2005).

• Incorvaia C, Frati F, Verna N, D'Alo S, Motolese A, Pucci S. Allergy and the skin. Clin. Exp. Immunol. 153 Suppl. 1: 27-29 (2008). *

• Inoue K, Kourin A, Watanabe T, Yamada M, Yasuda H, Yoshiba M. Plasma exchange in combination with online-hemodiafiltration as a promising method for purifying the blood of fulminant hepatitis patients. Hepatol. Res. 38 (s1: The 6 Japan Society of Hepatology Single Topic Conference: Liver Failure: Recent Progress and Pathogenesis to Management. 28-29 September 2007, Iwate, Japan): S46-S51 (2008). *

• Iovine A, Fimiani F, Vassallo P, Alessio M, Magli A. Ocular manifestations in a case of childhood cicatricial pemphigoid. Eur. J. Ophthalmol. 18: 636-638 (2008).

• Ito K, Mitchell DG, Outwater EK. Pancreatic changes in primary sclerosing cholangitis: evaluation with MR imaging. AJR Am. J. Roentgenol. 173: 1535-1539 (1999). *

• Ito M, Yasuo M, Yamamoto H, Tsushima K, Tanabe T, Yokoyama T, Hamano H, Kawa S, Uehara T, Honda T, Kawakami S, Kubo K. Central airway stenosis in a patient with autoimmune pancreatitis. Eur. Respir. J. 33: 680-683 (2009).

• Iwazu Y, Nemoto J, Okuda K, Nakazawa E, Hashimoto A, Fujio Y, Sakamoto M, Ando Y, Muto S, Kusano E. A case of minimal change nephrotic syndrome with acute renal failure complicating Hashimoto's disease. Clin. Nephrol. 69: 47-52 (2008).

• Izawa N, Sawada T, Itoh F. Cause of lower limb edema and hypoproteinemia diagnosed by double-balloon endoscopy. Gastroenterology 137: e1-e2 (2009). *

• Jacob A, Hensley LK, Safratowich BD, Quigg RJ, Alexander JJ. The role of the complement cascade in endotoxin-induced septic encephalopathy. Lab. Invest. 87: 1186-1194 (2007). *

• Jahoor F, Badaloo A, Reid M, Forrester T. Glycine production in severe childhood undernutrition. Am. J. Clin. Nutr. 84: 143-149 (2006). *

• Jain R, Chetty R. Gastric hyperplastic polyps: a review. Dig. Dis. Sci. 54: 1839-1846 (2009). *

• Jalan R, Shawcross D, Davies N. The molecular pathogenesis of hepatic encephalopathy. Int. J. Biochem. Cell Biol. 35: 1175-1181 (2003). *

• Jansen CA, Kostense S, Vandenberghe K, Nanlohy NM, De Cuyper IM, Piriou E, Manting EH, Miedema F, van Baarle D. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection. Eur. J. Immunol. 35: 150-158 (2005). *

• Jansen CA, van Baarle D, Miedema F. HIV-specific CD4(+) T cells and viremia: who's in control? Trends Immunol. 27: 119-124 (2006). *

• Jarrett SJ, Sivera F, Cawkwell LS, Marzo-Ortega H, McGonagle DG, Hensor E, Coates L, O'Connor PJ, Fraser A, Conaghan PG, Emery P. MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib. Ann. Rheum. Dis. 68: 1466-1469 (2009).

• Jayawardene SA, Sheerin N, Pattison JM, Hartley B, Goldsmith DJ. Spontaneous abdominal hemorrhage with AA-amyloidosis and vasculitis in a patient with rheumatoid arthritis. J. Clin. Rheumatol. 7: 86-90 (2001).

• Jeffers M, McDonald WF, Chillakuru RA, Yang M, Nakase H, Deegler LL, Sylander ED, Rittman B, Bendele A, Sartor RB, Lichenstein HS. A novel human fibroblast growth factor treats experimental intestinal inflammation. Gastroenterology 123: 1151-1162 (2002). *

• Jenneck C, Juergens U, Buecheler M, Novak N. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann. Allergy Asthma Immunol. 99: 13-21 (2007).

• Jiang W, Desjardins P, Butterworth RF. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline. J. Neurochem. 109: 485-493 (2009).

• Jiang W, Desjardins P, Butterworth RF. Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia. J. Cereb. Blood Flow Metab. 29: 944-952 (2009).

• Jiang Y, Lv LZ, Cai QC, Zhang K, Hu HZ, Zhang SG, Yang F, Wei WM, Zhang XJ, Chen YB, Pan F. Liver transplant for 70 patients with end-stage liver diseases. Hepatobiliary Pancreat. Dis. Int. 6: 24-28 (2007). *

• Jin CH, Chae SY, Kim TH, Yang HK, Lee EY, Song YW, Jo DG, Lee KC. Effect of TNF-related apoptosis-inducing ligand (TRAIL) on the reduction of joint inflammation in experimental rheumatoid arthritis. J. Pharmacol. Exp. Ther. Nov 20 [Epub ahead of print] (2009). *

• Jin X, Wang L, Wu HS, Zhang L, Wang CY, Tian Y, Zhang JH. N-Acetylcysteine inhibits activation of Toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemia-reperfusion injury in mice. Hepatobiliary Pancreat. Dis. Int. 6: 284-289 (2007). *

• Jo YJ, Choi HS, Jun DW, Lee OY, Kang JS, Park IG, Jung KH, Hahm JS. The effects of a new human leukocyte elastase inhibitor (recombinant guamerin) on cerulein-induced pancreatitis in rats. Int. Immunopharmacol. 8: 959-966 (2008).

• Johnson W Jr. Final report on the safety assessment of Capsicum annuum extract, Capsicum annuum fruit extract, Capsicum annuum resin, Capsicum annuum fruit powder, Capsicum frutescens fruit, Capsicum frutescens fruit extract, Capsicum frutescens resin, and capsaicin. Int. J. Toxicol. 26 Suppl. 1: 3-106 (2007). *

• Jolles S, Hughes J. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema. Int. Immunopharmacol. 6: 579-591 (2006).

• Jover R, Rodrigo R, Felipo V, Insausti R, Saez-Valero J, Garcia-Ayllon MS, Suarez I, Candela A, Compan A, Esteban A, Cauli O, Auso E, Rodriguez E, Gutierrez A, Girona E, Erceg S, Berbel P, Perez-Mateo M. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: a model of hepatic encephalopathy in cirrhosis. Hepatology 43: 1257-1266 (2006). *

• Kaaroud H, Boubaker K, Beji S, Abderrahim E, Moussa FB, Turki S, Goucha R, Hedri H, El Younsi F, Kheder A, Maiz HB. Renal amyloidosis followed more than 5 years: report of 12 cases. Transplant. Proc. 36: 1796-1798 (2004). *

• Kabuki T, Ogimi C, Tanaka R, Ikematsu K, Joh K, Kagimoto S, Oh-Ishi T. Thalidomide therapy for infantile-onset Crohn's disease. Nihon Rinsho Meneki Gakkai Kaishi 28: 92-98 (2005).

• Kadoshima-Yamaoka K, Goto M, Murakawa M, Yoshioka R, Tanaka Y, Inoue H, Murafuji H, Kanki S, Hayashi Y, Nagahira K, Ogata A, Nakatsuka T, Fukuda Y. ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-alpha level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate- induced skin inflammation model in mice. Eur. J. Pharmacol. 613: 163-166 (2009).

• Kaiserling E. Newly-formed lymph nodes in the submucosa in chronic inflammatory bowel disease. Lymphology 34: 22-29 (2001). *

• Kaithwas G, Majumdar DK. Therapeutic effect of Linum usitatissimum (flaxseed/linseed) fixed oil on acute and chronic arthritic models in albino rats. Inflammopharmacology Feb 16 [Epub ahead of print] (2010).

• Kallel L, Nijaa N, Fatma LB, Rais L, Mustapha NB, Matri S, Karoui S, Fekih M, Boubaker J, Moussa FB, Filali A. Familial cases of glomerulonephritis complicating Crohn's disease. Journal of Crohn's and Colitis 3: 125-127 (2009).

• Kandil E, Lin YY, Bluth MH, Zhang H, Levi G, Zenilman ME. Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins. World J. Gastroenterol. 12: 6806-6811 (2006). *

• Kanz MF, Dugas TR, Liu H, Santa Cruz V. Glutathione depletion exacerbates methylenedianiline toxicity to biliary epithelial cells and hepatocytes in rats. Toxicol. Sci. 74: 447-456 (2003). *

• Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clin. Exp. Allergy 39: 777-787 (2009). *

• Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK. Treatment of chronic autoimmune urticaria with omalizumab. J. Allergy Clin. Immunol. 122: 569-573 (2008). *

• Kaposi Novak P, Schmidt Z. Polymyalgia rheumatica. Orv. Hetil. 147: 1791-1802 (2006).

• Karagozian R, Burakoff R. The role of mesalamine in the treatment of ulcerative colitis. Ther. Clin. Risk Manag. 3: 893-903 (2007). *

• Karsten C, Schneider J, Teyssen S, Huppertz HI. Acute pancreatitis - association with a Campylobacter coli-infection. Z. Gastroenterol. 45: 961-964 (2007).

• Kasliwal R, Wilton LV, Shakir SA. Monitoring the safety of pioglitazone: results of a prescription-event monitoring study of 12,772 patients in England. Drug Saf. 31: 839-850 (2008).

• Kasuga K, Yang R, Porter TF, Agrawal N, Petasis NA, Irimia D, Toner M, Serhan CN. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J. Immunol. 181: 8677-8687 (2008). *

• Katz KA, Yan AC, Turner ML. Aquagenic wrinkling of the palms in patients with cystic fibrosis homozygous for the delta F508 CFTR mutation. Arch. Dermatol. 141: 621-624 (2005). *

• Kelly DA. Managing liver failure. Postgrad. Med. J. 78: 660-667 (2002). *

• Kemp EH, Ridgway JN, Smith KA, Watson PF, Weetman AP. Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease. Clin. Endocrinol. (Oxf.) 53: 291-299 (2000). *

• Kendall DM, Rubin CJ, Mohideen P, Ledeine JM, Belder R, Gross J, Norwood P, O'Mahony M, Sall K, Sloan G, Roberts A, Fiedorek FT, Defronzo RA. Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin … Diabetes Care 29: 1016-1023 (2006). *

• Ketabchi S, Massi D, Ficarra G, Rubino I, Franchi A, Paglierani M, Simoni A, Capodiferro S, Favia G, Maiorano E, Tarantini F, Cirino G, Santucci M. Expression of protease-activated receptor-1 and -2 in orofacial granulomatosis. Oral Dis. 13: 419-425 (2007).

• Khalaf AT, Li W, Jinquan T. Current advances in the management of urticaria. Arch. Immunol. Ther. Exp. (Warsz.) 56: 103-114 (2008).

• Khalilzadeh O, Mojazi Amiri H, Tahvildari M, Anvari M, Esteghamati A, Mobarra Z, Tehranchinia Z, Rashidi A, Amirzargar A. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy. Arch. Dermatol. Res. 301: 719-723 (2009). *

• Khan MN, Cho JY, Lee MC, Kang JY, Park NG, Fujii H, Hong YK. Isolation of two anti-inflammatory and one pro-inflammatory polyunsaturated fatty acids from the brown seaweed Undaria pinnatifida. J. Agric. Food Chem. 55: 6984-6988 (2007). *

• Khan S, Tarzi MD, Dore PC, Sewell WA, Longhurst HJ. Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema. Clin. Immunol. 123: 14-17 (2007). *

• Khayyal MT, El-Ghazaly MA, El-Hazek RM, Nada AS. The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats. Inflammopharmacology Oct 2 [Epub ahead of print] (2009).

• Khemiri M, Ben Rhouma A, Bouzid S, Messaoud T, Guesmi M, Hamzaoui M, Fattoum S, Khaldi F, Barsaoui S. Clinical characteristics and outcome of cystic fibrosis: report of 16 cases. Tunis. Med. 86: 567-572 (2008).

• Kim BJ, Kazim M. Prominent premalar and cheek swelling: a sign of thyroid-associated orbitopathy. Ophthal. Plast. Reconstr. Surg. 22: 457-460 (2006).

• Kim G. Primary (idiopathic) cold urticaria and cholinergic urticaria. Dermatol. Online J. 10: 13 (2004). *

• Kim J, Kim Y, Kim HT, Kim DW, Ha Y, Kim J, Kim CH, Lee I, Song K. TC1(C8orf4) is a novel endothelial inflammatory regulator enhancing NF-kappaB activity. J. Immunol. 183: 3996-4002 (2009).

• Kim MY, Noh JH. A case of Kawasaki disease with colonic edema. J. Korean Med. Sci. 23: 723-726 (2008). *

• Kim S, Hong I, Hwang JS, Choi JK, Rho HS, Kim DH, Chang I, Lee SH, Lee MO, Hwang JS. Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin. Mol. Med. 12: 17-24 (2006). *

• Kim SH, Choi JH, Lee KW, Kim SH, Shin ES, Oh HB, Suh CH, Nahm DH, Park HS. The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria. Clin. Exp. Allergy 35: 339-344 (2005). *

• Kim SH, Lee JE, Kim SH, Jee YK, Kim YK, Park HS, Min KU, Park HW; The Adverse Drug Reaction Research Group in Korea. Allelic variants of CD40 and CD40L genes interact to promote antibiotic-induced cutaneous allergic reactions. Clin. Exp. Allergy Sep 3 [Epub ahead of print] (2009). *

• Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Krom RA, Dickson ER. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl. 6: 489-494 (2000). *

• Kim YW, Zhao RJ, Park SJ, Lee JR, Cho IJ, Yang CH, Kim SG, Kim SC. Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production. Br. J. Pharmacol. 154: 165-173 (2008). *

• Kimberley FC, Medema JP, Hahne M. APRIL in B-cell malignancies and autoimmunity. Results Probl. Cell Differ. Jan 14 [Epub ahead of print] (2009).

• Kinebuchi S, Oohashi K, Takada T, Moriyama H, Yoshizawa H, Kobayashi O, Suzuki E, Gejyo F. Tracheo-bronchitis associated with Crohn's disease improved on inhaled corticotherapy. Intern. Med. 43: 829-834 (2004). *

• Kira J. To search for the pathogenesis of multiple sclerosis from the bedside. Rinsho Shinkeigaku 48: 931-933 (2008).

• Kishimoto M, Nasir A, Mor A, Belmont HM. Acute gastrointestinal distress syndrome in patients with systemic lupus erythematosus. Lupus 16: 137-141 (2007). *

• Knox DL. Psoriasis and intraocular inflammation. Trans. Am. Ophthalmol. Soc. 77: 210-224 (1979). *

• Koegel H, von Tobel L, Schafer M, Alberti S, Kremmer E, Mauch C, Hohl D, Wang XJ, Beer HD, Bloch W, Nordheim A, Werner S. Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice. J. Clin. Invest. 119: 899-910 (2009). *

• Kogure T, Hoshino A, Ito K, Sato H, Tatsumi T, Ohyama Y, Kawata E, Fujita K, Tamura J. Beneficial effect of complementary alternative medicine on lymphedema with rheumatoid arthritis. Mod. Rheumatol. 15: 445-449 (2005).

• Koksal AS, Ertugrul I, Disibeyaz S, Tola M, Kacar S, Arhan M, Aydin F, Ulker A. Crohn's and Behcet's disease association presenting with superior vena cava thrombosis. Dig. Dis. Sci. 50: 1698-1701 (2005). *

• Kondo S, McKenzie RC, Sauder DN. Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J. Invest. Dermatol. 103: 811-814 (1994). *

• Kontogiorgis CA, Savvoglou K, Hadjipavlou-Litina DJ. Antiinflammatory and antioxidant evaluation of novel coumarin derivatives. J. Enzyme Inhib. Med. Chem. 21: 21-29 (2006).

• Koreishi A, Lauwers GY, Misdraji J. Pneumatosis intestinalis: a challenging biopsy diagnosis. Am. J. Surg. Pathol. 31: 1469-1475 (2007).

• Korkmaz M, Gur G, Yilmaz U, Karakayali H, Boyacioglu S, Haberal M. Colonoscopy is a useful diagnostic tool for transplant recipients with lower abdominal symptoms. Transplant. Proc. 36: 190-192 (2004). *

• Kose M, Pekcan S, Kiper N, Aslan AT, Cobanoglu N, Yalcin E, Dogru D, Ozcelik U. Doll-like face: is it an underestimated clinical presentation of cystic fibrosis? Pediatr. Pulmonol. 43: 634-637 (2008).

• Koufany M, Moulin D, Bianchi A, Muresan M, Sebillaud S, Netter P, Weryha G, Jouzeau JY. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Arthritis Res. Ther. 10: R6 (2008). *

• Koukoulis GK, Koso-Thomas AK, Zardi L, Gabbiani G, Gould VE. Enhanced tenascin expression correlates with inflammation in primary sclerosing cholangitis. Pathol. Res. Pract. 195: 727-731 (1999).

• Koul PB, Sussmane JB. Metabolic hyperglycemic emergencies with acute pancreatitis in a child with known insulin-dependent diabetes mellitus. Eur. J. Emerg. Med. 12: 309-311 (2005).

• Kretschmer NW, Boor PJ, el Azhary RA, Ahmed AE, Reynolds ES. Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicity. III. Ultrastructural characterization of bile duct injury. Cancer Chemother. Pharmacol. 19: 109-117 (1987).

• Krishnan RS, Hsu S. Serum sickness due to infliximab in a patient with psoriasis. J. Drugs Dermatol. 3: 305-308 (2004).

• Kudari A, Wig JD, Vaiphei K, Kochhar R, Majumdar S, Gupta R, Yadav TD, Doley RP. Histopathological sequential changes in sodium taurocholate-induced acute pancreatitis. JOP 8: 564-572 (2007). *

• Kulikov AV, Stepanova MS, Stvolinsky SL, Hudoerkov RM, Voronkov DN, Rzhaninova AA, Goldstein DV, Boldyrev AA. Application of multipotent mesenchymal stromal cells from human adipose tissue for compensation of neurological deficiency induced by 3-nitropropionic acid in rats. Bull. Exp. Biol. Med. 145: 514-519 (2008).

• Kuloglu Z, Kansu A, Demirceken F, Bozkir M, Kundakci N, Bingol-Kologlu M, Girgin N. Crohn's disease of the vulva in a 10-year-old girl. Turk. J. Pediatr. 50: 197-199 (2008).

• Kumar S, Ghoshal UC, Aggarwal R, Saraswat VA, Choudhuri G. Severe ulcerative colitis: prospective study of parameters determining outcome. J. Gastroenterol. Hepatol. 19: 1247-1252 (2004). *

• Kwon OS, Park YS, Choi JH, Kim SH, Song MH, Lee HH, Jeon DW, Kim NI. A case of ulcerative colitis relapsed by influenza vaccination. Korean J. Gastroenterol. 49: 327-330 (2007).

• Lann MA, Lovell MA, Kleinschmidt-Demasters BK. Acute hemorrhagic leukoencephalitis: a critical entity for forensic pathologists to recognize. Am. J. Forensic Med. Pathol. Dec 14 [Epub ahead of print] (2009).

• Lao L, Fan AY, Zhang RX, Zhou A, Ma ZZ, Lee DY, Ren K, Berman B. Anti-hyperalgesic and anti-inflammatory effects of the modified Chinese herbal formula Huo Luo Xiao Ling Dan (HLXL) in rats. Am. J. Chin. Med. 34: 833-844 (2006).

• Larsen PJ, Lykkegaard K, Larsen LK, Fleckner J, Sauerberg P, Wassermann K, Wulff EM. Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone. Eur. J. Pharmacol. 596: 173-179 (2008).

• Lashner BA. Clinical advances in ulcerative colitis. American College of Gastroenterology 68th Annual Scientific Meeting and Postgraduate Course, October 10 - 15, 2003, Baltimore, Maryland (2003).

• Latella G, Sferra R, Vetuschi A, Zanninelli G, D'Angelo A, Catitti V, Caprilli R, Gaudio E. Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid. Eur. J. Clin. Invest. 38: 410-420 (2008).

• Laukkarinen JM, van Acker GJ, Weiss E, Steer ML, Perides G. A mouse model of acute biliary pancreatitis induced by retrograde pancreatic duct infusion of Na-taurocholate. Gut 56: 1590-1598 (2007). *

• Laura A, Samantha B, Caterina C, Paolo F. Atopic dermatitis exclusively localized on nipples and areolas. Pediatr. Dermatol. 22: 64-66 (2005).

• Lavy A, Naveh Y, Coleman R, Mokady S, Werman MJ. Dietary Dunaliella bardawil, a beta-carotene-rich alga, protects against acetic acid-induced small bowel inflammation in rats. Inflamm. Bowel Dis. 9: 372-379 (2003). *

• Lawson TL, Thorsen MK, Erickson SJ, Perret RS, Quiroz FA, Foley WD. Periportal halo: a CT sign of liver disease. Abdom. Imaging 18: 42-46 (1993). *

• Lawson-Yuen A, Levy HL. The use of betaine in the treatment of elevated homocysteine. Mol. Genet. Metab. 88: 201-207 (2006). *

• Lazaridis KN, Lindor KD. Primary biliary cirrhosis. Curr. Treat. Options Gastroenterol. 2: 473-480 (1999).

• Lazebnik LB, Parfenov AI. Crohn’s disease of small intestine: versions of clinical picture and problems of differential diagnosis. Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, pp. 43-44 (2006). *

• Le Parc JM. Inflammatory arthritis of the elderly. Rev. Prat. 55: 2115-2120 (2005).

• Leao JC, Hodgson T, Scully C, Porter S. Review article: orofacial granulomatosis. Aliment. Pharmacol. Ther. 20: 1019-1027 (2004). *

• Lech T, Hydzik P, Kosowski B. Significance of copper determination in late onset of Wilson's disease. Clin. Toxicol. (Phila.) 45: 688-694 (2007). *

• Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 55: 165-168 (1995).

• Lee DY, Choo BK, Yoon T, Cheon MS, Lee HW, Lee AY, Kim HK. Anti-inflammatory effects of Asparagus cochinchinensis extract in acute and chronic cutaneous inflammation. J. Ethnopharmacol. 121: 28-34 (2009).

• Lee EY, Sundel RP, Kim S, Zurakowski D, Kleinman PK. MRI findings of juvenile psoriatic arthritis. Skeletal Radiol. 37: 987-996 (2008).

• Lee HS. Diagnosis and predicting severity in acute pancreatitis. Korean J. Gastroenterol. 46: 333-338 (2005).

• Lee JC, Krochak R, Blouin A, Kanterakis S, Chatterjee S, Arguiri E, Vachani A, Solomides CC, Cengel KA, Christofidou-Solomidou M. Dietary flaxseed prevents radiation-induced oxidative lung damage, inflammation and fibrosis in a mouse model of thoracic radiation injury. Cancer Biol. Ther. 8: 47-53 (2009).

• Lee KH, Choi EM. Effect of pine pollen extract on experimental chronic arthritis. Phytother. Res. 23: 651-657 (2009).

• Lee SI, Kim BS, Kim KS, Lee SK, Shin KS, Lim JS. Immune-suppressive activity of punicalagin via inhibition of NFAT activation. Biochem. Biophys. Res. Commun. 371: 799-803 (2008). *

• Lee SJ, Choi MG. Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients. Metabolism 55: 1681-1688 (2006). *

• Lee YM, Seon MR, Cho HJ, Kim JS, Park JH. Benzyl isothiocyanate exhibits anti-inflammatory effects in murine macrophages and in mouse skin. J. Mol. Med. Sep 17 [Epub ahead of print] (2009). *

• Lefkowitch JH. Histological assessment of cholestasis. Clin. Liver Dis. 8: 27-40 (2004).

• Lefkowitch JH. Hepatobiliary pathology. Curr. Opin. Gastroenterol. 23: 221-231 (2007).

• Leighton JA, Legnani P, Seidman EG. Role of capsule endoscopy in inflammatory bowel disease: where we are and where we are going. Inflamm. Bowel Dis. 13: 331-337 (2007). *

• Lekpa FK, Economu-Dubosc A, Fevre C, Claudepierre P, Chevalier X. Efficacy of etanercept in lymphedema associated with psoriatic arthritis. J. Rheumatol. 36: 207-208 (2009).

• Lemberg A, Fernandez MA. Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress. Ann. Hepatol. 8: 95-102 (2009). *

• Lengeling RW, Mitros FA, Brennan JA, Schulze KS. Ulcerative ileitis encountered at ileo-colonoscopy: likely role of nonsteroidal agents. Clin. Gastroenterol. Hepatol. 1: 160-169 (2003). *

• Lequerre T, Vittecoq O, Saugier-Veber P, Goldenberg A, Patoz P, Frebourg T, Loet XL. A cryopyrin-associated periodic syndrome with joint destruction. Rheumatology (Oxford) 46: 709-714 (2007). *

• Lerch MM, Hoppe-Seyler P, Gerok W. Origin and development of exocrine pancreatic insufficiency in experimental renal failure. Gut 35: 401-407 (1994). *

• Leuschner U, Manns MP, Eisebitt R. Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis. Z. Gastroenterol. 43: 1051-1059 (2005).

• Levang J, Muller P, Girardin P, Humbert P. Sweet's syndrome and phenylbutazone-induced sialadenitis. Ann. Dermatol. Venereol. 135: 291-294 (2008).

• Levin MH, Verkman AS. Aquaporins and CFTR in ocular epithelial fluid transport. J. Membr. Biol. 210: 105-115 (2006). *

• Levy AS, Simon OR, Shelly J, Gardener M. 6-Shogaol reduced chronic inflammatory response in the knees of rats treated with complete Freunds adjuvant. BMC Pharmacol. 6: 12 (2006). *

• Li MK, Crawford JM. The pathology of cholestasis. Semin. Liver Dis. 24: 21-42 (2004).

• Liao CH, Huang JL. Juvenile ankylosing spondylitis with uveitis. Asian Pac. J. Allergy Immunol. 21: 69-71 (2003).

• Licata G, Tuttolomondo A, Licata A, Parrinello G, DI Raimondo D, DI Sciacca R, Camma C, Craxi A, Paterna S, Pinto A. Clinical trial: high-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. Aliment. Pharmacol. Ther. 30: 227-235 (2009). *

• Lim LL, Scarborough JD, Thorne JE, Graham E, Kempen JH, Mackensen F, Nguyen QD, Prabriputaloong T, Read RW, Suhler EB, Schwartz JM, Smith JR. Uveitis in patients with autoimmune hepatitis. Am. J. Ophthalmol. 147: 332-338.e1 (2009). *

• Lin BC, Sullivan R, Lee Y, Moran S, Glover E, Bradfield CA. Deletion of the aryl hydrocarbon receptor associated protein 9 leads to cardiac malformation and embryonic lethality. J. Biol. Chem. 282: 35924-35932 (2007). *

• Lindzen E, Jewells V, Bouldin T, Speer D, Royal W 3rd, Markovic-Plese S. Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy. J. Neurovirol. 14: 569-573 (2008).

• Listrom C, Holt K. Inflammatory bowel disease. Emerg. Med. 36: 24-28 (2004).

• Liu H, Li Y, Wang L, Chen H, Guan J, Zhou Z. Aggravation of acute pancreatitis by heparan sulfate in mice. Scand. J. Gastroenterol. 44: 626-632 (2009). *

• Liu YM, Yan HP, Tan YF, Liu Y, Feng X, Kong SL. Clinical and laboratory characteristics of anti-soluble liver antigen/liver-pancreas (SLA/LP) autoantibody positive liver disease patients. Zhonghua Gan Zang Bing Za Zhi 13: 927-929 (2005).

• Liu ZH, Peng JS, Li CJ, Yang ZL, Xiang J, Song H, Wu XB, Chen JR, Diao DC. A simple taurocholate-induced model of severe acute pancreatitis in rats. World J. Gastroenterol. 15: 5732-5739 (2009). *

• Llovet JM, Bartolí R, Planas R, Cabre E, Jimenez M, Urban A, Ojanguren I, Arnal J, Gassull MA. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut 35: 1648-1652 (1994). *

• Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the antiinflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 67: 15-19 (2005). *

• Lockard O Jr, Harmon C, Nolph K, Irvin W. Allergic reaction to allopurinol with cross-reactivity to oxypurinol. Ann. Intern. Med. 85: 333-335 (1976).

• Lopez V, Alonso V, Monteagudo C, Marti N, Pereda C, Ramon D, Jorda E. Penile and scrotal edema as a manifestation of Crohn's disease. Int. J. Dermatol. 48: 1136-1137 (2009). *

• Lu S, Tran TA, Jones DM, Meyer DR, Ross JS, Fisher HA, Carlson JA. Localized lymphedema (elephantiasis): a case series and review of the literature. J. Cutan. Pathol. 36: 1-20 (2009). *

• Lu SC, Gukovsky I, Lugea A, Reyes CN, Huang ZZ, Chen L, Mato JM, Bottiglieri T, Pandol SJ. Role of S-adenosylmethionine in two experimental models of pancreatitis. FASEB J. 17: 56-58 (2003). *

• Lucas R, Verin AD, Black SM, Catravas JD. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem. Pharmacol. 77: 1763-1772 (2009). *

• Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1: 632-640 (1981).

• Luna-Medina R, Cortes-Canteli M, Sanchez-Galiano S, Morales-Garcia JA, Martinez A, Santos A, Perez-Castillo A. NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders. J. Neurosci. 27: 5766-5776 (2007).

• Lychkova AE. Mechanisms of a serotoninergic syndrome development. Usp. Fiziol. Nauk. 40: 47-71 (2009).

• Mahadevan U, Sandborn WJ. Evolving medical therapies for Crohn's disease. Curr. Gastroenterol. Rep. 3: 471-476 (2001).

• Mahajan S, Koranne RV, Sharma SK. Cutaneous manifestation of diabetes melitus. Indian J. Dermatol. Venereol. Leprol. 69: 105-108 (2003).

• Mahgoub A, El-Medany A, Mustafa A, Arafah M, Moursi M. Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. Toxicol. Appl. Pharmacol. 205: 43-52 (2005).

• Mailhol C, Tremeau-Martinage C, Paul C, Godel A, Lamant L, Giordano-Labadie F. Severe drug hypersensitivity reaction (DRESS syndrome) to doxycycline. Ann. Dermatol. Venereol. 137: 40-43 (2010).

• Maione F, Pashalidis N, Mascolo N, Dufton N, Perretti M, D'Acquisto F. Interleukin 17 sustains rather than induces inflammation. Biochem. Pharmacol. 77: 878-887 (2009). *

• Malaviya R, Ansell J, Hall L, Fahmy M, Argentieri RL, Olini GC Jr, Pereira DW, Sur R, Cavender D. Targeting cytosolic phospholipase A(2) by arachidonyl trifluoromethyl ketone prevents chronic inflammation in mice. Eur. J. Pharmacol. 539: 195-204 (2006). *

• Male PJ, Schaer B, Posternak F. Hypersensitivity reaction to allopurinol. Schweiz. Med. Wochenschr. 108: 681-683 (1978).

• Malomuzh OI, Krel' PE, Got'e SV, Tsirul'nikova OM. Prognosis for patients with chronic diseases of the liver in formulating indications to orthotopic liver transplantation. Ter. Arkh. 81: 45-50 (2009).

• Mao F, Xu WR, Qian H, Zhu W, Yan YM, Shao QX, Xu HX. Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis. Inflamm. Res. Sep 10 [Epub ahead of print] (2009). *

• Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130: 2800-2815 (2007). *

• Maron MB, Luther DJ, Pilati CF, Ohanyan V, Li T, Koshy S, Horne WI, Meszaros JG, Walro JM, Folkesson HG. beta-Adrenoceptor stimulation of alveolar fluid clearance is increased in rats with heart failure. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L487-L495 (2009). *

• Marquez E, Sanchez-Fidalgo S, Calvo JR, Lastra CA, Motilva V. Acutely administered melatonin is beneficial while chronic melatonin treatment aggravates the evolution of TNBS-induced colitis. J. Pineal Res. 40: 48-55 (2006).

• Martin AR, Villegas I, La Casa C, Alarcon de la Lastra C. The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats. Eur. J. Pharmacol. 481: 281-291 (2003). *

• Martin DR, Danrad R, Herrmann K, Semelka RC, Hussain SM. Magnetic resonance imaging of the gastrointestinal tract. Top. Magn. Reson. Imaging 16: 77-98 (2005).

• Martin L, Rubin A, Tran K, Pas H, Marr P, Edmonds J, Murrell D. A complicated blistering disease case demonstrating the usefulness of immunoblotting and ELISA for the diagnosis of immunobullous diseases. Australas. J. Dermatol. 47: A57 (2006).

• Marzo-Ortega H, McGonagle D, O'Connor P, Hensor EM, Bennett AN, Green MJ, Emery P. Baseline and one year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. The relationship between symptoms, HLA-B27, and disease extent and persistence. Ann. Rheum. Dis. 68: 1721-1727 (2009).

• Marzo-Ortega H, Tanner SF, Rhodes LA, Tan AL, Conaghan PG, Hensor EM, Radjenovic A, O'Connor P, Emery P, McGonagle D. Magnetic resonance imaging in the assessment of metacarpophalangeal joint disease in early psoriatic and rheumatoid arthritis. Scand. J. Rheumatol. 38: 79-83 (2009). *

• Masato Y. Regulation, structure and function of brain aquaporin. Rinsho Shinkeigaku 49: 786-788 (2009).

• Mascarenhas MR. Treatment of gastrointestinal problems in cystic fibrosis. Curr. Treat. Options Gastroenterol. 6: 427-441 (2003).

• Maspero JF, Parisi CA, De Gennaro M, Benhabib O, Lampert M. Chronic autoimmune urticaria: treatment with omalizumab. Arch. Argent. Pediatr. 107: 452-456 (2009).

• Matsunaga A, Yoneda M. Anti-NAE autoantibodies and clinical spectrum in Hashimoto's encephalopathy. Rinsho Byori 57: 271-278 (2009).

• Mayo MJ. Patients and patience: the pitfalls of primary biliary cirrhosis trials. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 552-553 (2005). *

• Mazzon E, Esposito E, Di Paola R, Muia C, Crisafulli C, Genovese T, Caminiti R, Meli R, Bramanti P, Cuzzocrea S. Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept. Clin. Exp. Immunol. 153: 136-149 (2008). *

• McCarron KF, Prayson RA. The neuropathology of orthotopic liver transplantation: an autopsy series of 16 patients. Arch. Pathol. Lab. Med. 122: 726-731 (1998).

• McQueen F, Lassere M, Duer-Jensen A, Wiell C, Conaghan PG, Gandjbakhch F, Hermann KG, Bird P, Boyesen P, Peterfy C, Ejbjerg B, Haavardsholm EA, Coates L, Ostergaard M. Testing an OMERACT MRI scoring system for peripheral psoriatic arthritis in cross-sectional and longitudinal settings. J. Rheumatol. 36: 1811-1815 (2009).

• McQueen FM, Dalbeth N. Predicting joint damage in rheumatoid arthritis using MRI scanning. Arthritis Res. Ther. 11: 124 (2009). *

• McQueen FM, Dalbeth N, Doyle A. MRI in psoriatic arthritis: insights into pathogenesis and treatment response. Curr. Rheumatol. Rep. 10: 303-310 (2008).

• Memis D, Hekimoglu S, Sezer A, Altaner S, Sut N, Usta U. Curcumin attenuates the organ dysfunction caused by endotoxemia in the rat. Nutrition 24: 1133-1138 (2008).

• Mieli-Vergani G, Vergani D. Approach to a child with chronic liver disease. J. Gastroenterol. Hepatol. 19: S377-S378 (2004). *

• Migaleddu V, Quaia E, Scano D, Virgilio G. Inflammatory activity in Crohn disease: ultrasound findings. Abdom. Imaging 33: 589-597 (2008). *

• Milia AF, Ibba-Manneschi L, Manetti M, Benelli G, Generini S, Messerini L, Matucci-Cerinic M. Evidence for the prevention of enthesitis in HLA-B27/hbeta2m transgenic rats treated with a monoclonal antibody against TNFalpha. J. Cell. Mol. Med. Dec 8 [Epub ahead of print] (2009).

• Minden K, Mingels A, Niewerth M, Heiligenhaus A, Ganser G. Juvenile idiopathic arthritis and uveitis: epidemiology including data from a national database. Klin. Monatsbl. Augenheilkd. 224: 469-472 (2007).

• Mirshahpanah P, Li YY, Burkhardt N, Asadullah K, Zollner TM. CCR4 and CCR10 ligands play additive roles in mouse contact hypersensitivity. Exp. Dermatol. 17: 30-34 (2008).

• Mitamura M, Nakano N, Yonekawa T, Shan L, Kaise T, Kobayashi T, Yamashita K, Kikkawa H, Kinoshita M. T cells are involved in the development of arthritis induced by anti-type II collagen antibody. Int. Immunopharmacol. 7: 1360-1368 (2007).

• Miwa Y, Moriwaki H. Nocturnal energy and BCAA supplementation in patients with liver cirrhosis. Hepatol. Res. 30S: 63-66 (2004).

• Miyajima S, Taguchi Y, Tanaka E, Inoue T, Sakuramoto M, Minakuchi M, Maeda Y, Maniwa K, Tanizawa K, Okamoto M, Takeda T. A case of pulmonary adenocarcinoma accompanied by minimal change nephrotic syndrome, antiphospholipid syndrome and warm-type autoimmune hemolytic anemia. Nihon Kokyuki Gakkai Zasshi 44: 631-635 (2006).

• Mizock BA, Demichele SJ. The acute respiratory distress syndrome: role of nutritional modulation of inflammation through dietary lipids. Nutr. Clin. Pract. 19: 563-574 (2004).

• Mobasheri A, Moskaluk CA, Marples D, Shakibaei M. Expression of aquaporin 1 (AQP1) in human synovitis. Ann. Anat. Jan 25 [Epub ahead of print] (2010).

• Mollinedo F, Gajate C, Morales AI, Del Canto-Janez E, Justies N, Collia F, Rivas JV, Modolell M, Iglesias A. Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis. J. Pharmacol. Exp. Ther. 329: 439-449 (2009). *

• Monnet D, Moachon L, Dougados M, Brezin AP. Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis. Nat. Clin. Pract. Rheumatol. 2: 393-397 (2006). *

• Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R, Dalesandro D, Delaet NG, Erb E, Ernst J, Gibbs A, Kahl J, Kessler L, Lundstrom J, Miller S, Nakanishi H, Roberts E, Saiah E, Sullivan R, Wang Z, Larson CJ. KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. Eur. J. Pharmacol. Feb 1 [Epub ahead of print] (2010). *

• Montalbano M, Neff GW, Yamashiki N, Meyer D, Bettiol M, Slapak-Green G, Ruiz P, Manten E, Safdar K, O'Brien C, Tzakis AG. A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications. Transplantation 78: 264-268 (2004).

• Monteiro AC, Scovino A, Raposo S, Gaze VM, Cruz C, Svensjo E, Narciso MS, Colombo AP, Pesquero JB, Feres-Filho E, Nguyen KA, Sroka A, Potempa J, Scharfstein J. Kinin danger signals proteolytically released by gingipain induce fimbriae-specific IFN-gamma- and IL-17-producing T cells in mice infected intramucosally with Porphyromonas gingivalis. J. Immunol. 183: 3700-3711 (2009).

• Moore-Olufemi SD, Padalecki J, Olufemi SE, Xue H, Oliver DH, Radhakrishnan RS, Allen SJ, Moore FA, Stewart R, Laine GA, Cox CS Jr. Intestinal edema: effect of enteral feeding on motility and gene expression. J. Surg. Res. 155: 283-292 (2009).

• Moreno C, Nicaise C, Gustot T, Quertinmont E, Nagy N, Parmentier M, Louis H, Deviere J. Chemokine receptor CCR5 deficiency exacerbates caerulein-induced acute pancreatitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G1089-G1099 (2006). *

• Morgenweck J, Abdel-Aleem OS, McNamara KC, Donahue RR, Badr MZ, Taylor BK. Activation of peroxisome proliferator activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. Neuropharmacology Nov 2 [Epub ahead of print] (2009).

• Moriwaki H, Shiraki M, Fukushima H, Shimizu M, Iwasa J, Naiki T, Nagaki M. Long-term outcome of branched-chain amino acid treatment in patients with liver cirrhosis. Hepatol. Res. 38 (s1: The 6 Japan Society of Hepatology Single Topic Conference: Liver Failure: Recent Progress and Pathogenesis to Management. 28-29 September 2007, Iwate, Japan): S102-S106 (2008). *

• Morris T, Stables M, Hobbs A, de Souza P, Colville-Nash P, Warner T, Newson J, Bellingan G, Gilroy DW. Effects of low-dose aspirin on acute inflammatory responses in humans. J. Immunol. 183: 2089-2096 (2009).

• Mukeba D, Chandrikakumari K, Giot JB, Leonard P, Meuris C, Frippiat F, Moutschen M. Autoimmune angioneurotic edema in a patient with Helicobacter pylori infection. Helicobacter 14: 9-11 (2009). *

• Mukherjee KK, Chhabra R, Khosla VK. Raised intracranial pressure in hepatic encephalopathy. Indian J. Gastroenterol. 22 Suppl. 2: S62-S65 (2003).

• Muller BA. Urticaria and angioedema: a practical approach. Am. Fam. Physician 69: 1123-1128 (2004). *

• Muller CA, Belyaev O, Appelros S, Buchler M, Uhl W, Borgstrom A. Dexamethasone affects inflammation but not trypsinogen activation in experimental acute pancreatitis. Eur. Surg. Res. 40: 317-324 (2008).

• Murtaugh PA, Dickson ER, Van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, Gips CH. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology 20: 126-134 (1994).

• Murthy AK, Dubose CN, Banas JA, Coalson JJ, Arulanandam BP. Contribution of polymeric immunoglobulin receptor to regulation of intestinal inflammation in dextran sulfate sodium-induced colitis. J. Gastroenterol. Hepatol. 21: 1372-1380 (2006). *

• Muscari F, Suc B, Aguirre J, Di Mauro GL, Bloom E, Duffas JP, Blanc P, Fourtanier G. Orthotopic liver transplantation with vena cava preservation in cirrhotic patients: is systematic temporary portacaval anastomosis a justified procedure? Transplant. Proc. 37: 2159-2162 (2005). *

• Nadauld LD, Sandoval IT, Chidester S, Yost HJ, Jones DA. Adenomatous polyposis coli control of retinoic acid biosynthesis is critical for zebrafish intestinal development and differentiation. J. Biol. Chem. 279: 51581-51589 (2004). *

• Nakajima H, Munakata A, Yoshida Y. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine. J. Gastroenterol. 30 Suppl. 8: 115-117 (1995).

• Nakajima M, Nakashima H, Kiyohara K, Sakatoku M, Fujimori H, Terahata S, Nobata H. A case of diffuse duodenitis and enteritis following total colectomy for ulcerative colitis. Nippon Shokakibyo Gakkai Zasshi 105: 382-390 (2008).

• Nakamura T, Kawagoe Y, Ueda Y, Koide H. Polymyxin B-immobilized fiber hemoperfusion in a patient with active ulcerative colitis. ASAIO J. 51: 471-473 (2005).

• Nakamura T, Kawagoe Y, Ueda Y, Koide H. Antineutrophil cytoplasmic autoantibody-associated rapidly progressive glomerulonephritis in a patient with primary biliary cirrhosis. Am. J. Med. Sci. 328: 176-179 (2004).

• Nakamura T, Suzuki Y, Koide H. Granulocyte and monocyte adsorption apheresis in a patient with antiglomerular basement membrane glomerulonephritis and active ulcerative colitis. Am. J. Med. Sci. 325: 296-398 (2003).

• Nakanuma Y, Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 76: 1326-1332 (1979).

• Narang VS, Fraga C, Kumar N, Shen J, Throm S, Stewart CF, Waters CM. Dexamethasone increases expression and activity of multi-drug resistance transporters at the rat blood-brain barrier. Am. J. Physiol. Cell Physiol. 295: C440-C450 (2008). *

• Narbutt J, Lesiak A, Kwiecien A, Sysa-Jedrzejowska A, Kuydowicz J. Scleroderma-like lesions in the course of autoimmune hepatitis. Case report. Przegl. Lek. 62: 314-316 (2005).

• Nardelli DT, Kevin Luk KH, Kotloski NJ, Warner TF, Torrealba JR, Callister SM, Schell RF. Role of IL-17, transforming growth factor-beta, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice. FEMS Immunol. Med. Microbiol. 53: 265-274 (2008). *

• Nasr SH, Markowitz GS, Reddy BS, Maesaka J, Swidler MA, D'Agati VD. Dysproteinemia, proteinuria, and glomerulonephritis. Kidney Int. 69: 772-775 (2006).

• Navarro-Xavier RA, Newson J, Silveira VL, Farrow SN, Gilroy DW, Bystrom J. A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J. Immunol. Dec 23 [Epub ahead of print] (2009).

• Negaard A, Paulsen V, Sandvik L, Berstad AE, Borthne A, Try K, Lygren I, Storaas T, Klow NE. A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis. Eur. Radiol. 17: 2294-2301 (2007).

• Negaard A, Sandvik L, Mulahasanovic A, Berstad AE, Klow NE. Magnetic resonance enteroclysis in the diagnosis of small-intestinal Crohn's disease: diagnostic accuracy and inter- and intra-observer agreement. Acta Radiol. 47: 1008-1016 (2006).

• Nezhinskaya GI, Sapronov NS, Vladykin AL, Shepeleva VV. Effects of cholinotropic and cytostatic drugs on the development of arthus reaction. Bull. Exp. Biol. Med. 146: 747-749 (2008).

• Nhu QM, Shirey K, Teijaro JR, Farber DL, Netzel-Arnett S, Antalis TM, Fasano A, Vogel SN. Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal Immunol. 3: 29-39 (2010). *

• Nishimura T, Andoh A, Nishida A, Shioya M, Koizumi Y, Tsujikawa T, Fujiyama Y. FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice. World J. Gastroenterol. 14: 5851-5856 (2008). *

• Noble MD, Romac J, Vigna SR, Liddle RA. A pH-sensitive, neurogenic pathway mediates disease severity in a model of post-ERCP pancreatitis. Gut 57: 1566-1571 (2008).

• Nocera A, Andorno E, Tagliamacco A, Morelli N, Bottino G, Ravazzoni F, Casaccia M, Barocci S, Alice S, Santori G, Ghirelli R, Valente U. Sirolimus therapy in liver transplant patients: an initial experience at a single center. Transplant. Proc. 40: 1950-1952 (2008). *

• Nofziger C, Brown KK, Smith CD, Harrington W, Murray D, Bisi J, Ashton TT, Maurio FP, Kalsi K, West TA, Baines DL, Blazer-Yost BL. PPARgamma agonists inhibit vasopressin mediated anion transport in the MDCK-C7 cell line. Am. J. Physiol. Renal Physiol. 297: F55-F62 (2009). *

• Nolte W, Figulla HR, Ringe B, Wiltfang J, Munke H, Hartmann H, Pausch J, Ramadori G. Refractory hydrothorax in primary biliary cirrhosis: successful treatment with transjugular intrahepatic portosystemic stent shunt. Dtsch. Med. Wochenschr. 122: 1275-1280 (1997).

• Novelli G, Rossi M, Pretagostini M, Pugliese F, Ruberto F, Novelli L, Nudo F, Bussotti A, Corradini S, Martelli S, Berloco PB. One hundred sixteen cases of acute liver failure treated with MARS. Transplant. Proc. 37: 2557-2559 (2005). *

• Novembre E, Cianferoni A, Mori F, Barni S, Calogero C, Bernardini R, Di Grande L, Pucci N, Azzari C, Vierucci A. Urticaria and urticaria related skin condition/disease in children. Eur. Ann. Allergy Clin. Immunol. 40: 5-13 (2008).

• Novinscak T, Brcic L, Staresinic M, Jukic I, Radic B, Pevec D, Mise S, Tomasovic S, Brcic I, Banic T, Jakir A, Buljat G, Anic T, Zoricic I, Romic Z, Seiwerth S, Sikiric P. Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat. Surg. Today 38: 716-725 (2008).

• O'Neal H, Olds J, Webster N. Managing patients with acute liver failure: developing a tool for practitioners. Nurs. Crit. Care 11: 63-68 (2006).

• Odze RD. Pathology of eosinophilic esophagitis: what the clinician needs to know. Am. J. Gastroenterol. 104: 485-490 (2009).

• Oh DC, Ng TM, Ho J, Leong KP. Systemic lupus erythematosus with concurrent protein-losing enteropathy and primary sclerosing cholangitis: a unique association. Lupus 15: 102-104 (2006). *

• Ohara M, Takahashi H, Suzuki C, Yamamoto M, Naishiro Y, Yamamoto H, Saga K, Shinomura Y, Imai K. A case of lupus erythematosus profundus followed by systemic lupus erythematosus presenting with severe intestinal involvement. Nihon Rinsho Meneki Gakkai Kaishi 30: 48-54 (2007).

• Ohashi I, Kaku R, Fuji H, Nakatsuka H, Matsumi M, Morita K. Severe acute pulmonary edema during living related liver transplantation surgery. Masui 53: 925-928 (2004).

• Oliveira AC, Bertollo CM, Rocha LT, Nascimento EB Jr, Costa KA, Coelho MM. Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma. Eur. J. Pharmacol. 561: 194-201 (2007). *

• Olivieri I, Pipitone N, D' Angelo S, Padula A, Salvarani C. Late-onset rheumatoid arthritis and late-onset spondyloarthritis. Clin. Exp. Rheumatol. 27: S139-S145 (2009).

• Olivieri I, Scarano E, Padula A, D'Angelo S. Imaging of psoriatic arthritis. Reumatismo 59 Suppl. 1: 73-76 (2007). *

• Olsson F, Denham M, Cole TJ, Hooper SB, Mollard R. Deriving respiratory cell types from stem cells. Curr. Stem Cell Res. Ther. 2: 197-208 (2007).

• Orr T, Noon A. An acutely erythematous, oedematous penis and antecubital fossae rash in a patient taking etanercept: a case report. Cases J. 2: 9116 (2009). *

• Oruc N, Ozutemiz AO, Nart VY, Celik HA, Yuce G, Batur Y. Infliximab: a new therapeutic agent in acute pancreatitis? Pancreas 28: E1-E8 (2004).

• Ovetchkine P. Secondary effects of vaccinations. Arch. Pediatr. 8: 316-320 (2001).

• Ozkavukcu E, Erden A, Erden I. Pancreatic changes in patients with primary sclerosing cholangitis: MR cholangiopancreatography and MRI findings. Eur. J. Radiol. 70: 118-121 (2009).

• Palazzi C, D'Amico E, Cacciatore P, Pennese E, Olivieri I. Non-rheumatoid erosive arthritis associated with type I hereditary angioedema. Clin. Rheumatol. 24: 632-633 (2005). *

• Pan GD, Cheng NS, Xiong XZ, Liu JW, Li SF, Zahng GF, Yan LN. A study on inflammatory regulation of human gallbladder epithelial cells by PPAR-gamma ligand. Sichuan Da Xue Xue Bao Yi Xue Ban 35: 658-661 (2004).

• Pan HC, Kao TK, Ou YC, Yang DY, Yen YJ, Wang CC, Chuang YH, Liao SL, Raung SL, Wu CW, Chiang AN, Chen CJ. Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J. Nutr. Biochem. 20: 715-725 (2009). *

• Pandey A, Kour K, Bani S, Suri KA, Satti NK, Sharma P, Qazi GN. Amelioration of adjuvant induced arthritis by apocynin. Phytother. Res. 23: 1462-1468 (2009).

• Panico A, Lupoli GA, Fonderico F, Colarusso S, Marciello F, Poggiano MR, Prete MD, Magliulo R, Iervolino P, Lupoli G. Multiple ovarian cysts in a young girl with severe hypothyroidism. Thyroid 17: 1289-1293 (2007).

• Papachristou GI, Demetris AJ, Craig F, Lee KKW, Rabinovitz M. Cholestatic jaundice and bone lesions in an elderly woman. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 53-57 (2004). *

• Park HJ, Ye YM, Hur GY, Kim SH, Park HS. Association between a TGFbeta1 promoter polymorphism and the phenotype of aspirin-intolerant chronic urticaria in a Korean population. J. Clin. Pharm. Ther. 33: 691-697 (2008). *

• Park JY, Park YS, Kim SY, Park DR, Jo YJ, Kim SH, Song MH, Lee HH. A case of ischemic colitis in a patient with Takayasu's arteritis. Korean J. Gastroenterol. 49: 110-113 (2007).

• Park Y, Nam S, Yi HJ, Hong HJ, Lee M. Dietary n-3 polyunsaturated fatty acids increase oxidative stress in rats with intracerebral hemorrhagic stroke. Nutr. Res. 29: 812-818 (2009).

• Paskonis M, Jurgaitis J, Mehrabi A, Kashfi A, Fonouni H, Strupas K, Buchler MW, Kraus TW. Surgical strategies for liver transplantation in the case of portal vein thrombosis - current role of cavoportal hemitransposition and renoportal anastomosis. Clin. Transplant. 20: 551-562 (2006). *

• Pastor CM, Pugin J, Kwak B, Chanson M, Mach F, Hadengue A, Frossard JL. Role of Toll-like receptor 4 on pancreatic and pulmonary injury in a mice model of acute pancreatitis associated with endotoxemia. Crit. Care Med. 32: 1759-1763 (2004).

• Patriquin H, Lenaerts C, Smith L, Perreault G, Grignon A, Filiatrault D, Boisvert J, Roy CC, Rasquin-Weber A. Liver disease in children with cystic fibrosis: US-biochemical comparison in 195 patients. Radiology 211: 229-232 (1999). *

• Patterson DS, Allen WM. Chronic mycobacterial enteritis in ruminants as a model of Crohn's disease. Proc. R. Soc. Med. 65: 998-1001 (1972). *

• Pecorella I, La Cava M, Mannino G, Pinca M, Pezzi PP. Diffuse granulomatous necrotizing scleritis. Acta Ophthalmol. Scand. 84: 263-265 (2006). *

• Pegorier JP. PPAR receptors and insulin sensitivity: new agonists in development. Ann. Endocrinol. (Paris) 66: 10-17 (2005).

• Pereira C, Tavares B, Carrapatoso I, Loureiro G, Faria E, Machado D, Chieira C. Low-dose intravenous gammaglobulin in the treatment of severe autoimmune urticaria. Allerg. Immunol. (Paris) 39: 237-242 (2007).

• Perente I, Utine CA, Cakir H, Kaya V, Tutkun IT, Yilmaz OF. Management of ocular complications of Vogt-Koyanagi-Harada syndrome. Int. Ophthalmol. 29: 33-37 (2009). *

• Perez A, Woods A, Grattan CE. Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria. Br. J. Dermatol. Nov 9 [Epub ahead of print] (2009). *

• Perides G, Laukkarinen JM, Vassileva G, Steer ML. Biliary acute pancreatitis in mice is mediated by the G protein-coupled cell surface bile acid receptor Gpbar1. Gastroenterology 138: 715-725 (2010). *

• Peterson JW, Dickey WD, Saini SS, Gourley W, Klimpel GR, Chopra AK. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease. Gut 39: 698-704 (1996). *

• Petithory JC. New data on anisakiasis. Bull. Acad. Natl. Med. 191: 53-65 (2007).

• Pezzana A, Boggio Bertinet D, Costantino AM, Da Pont MC, Pera A. Possibilities and limitations of nutritional support in Crohn disease. Minerva Gastroenterol. Dietol. 38: 161-165 (1992).

• Pezzilli R, Fantini L, Morselli-Labate AM. New approaches for the treatment of acute pancreatitis. JOP 7: 79-91 (2006). *

• Pfarr KM, Debrah AY, Specht S, Hoerauf A. Filariasis and lymphoedema. Parasite Immunol. 31: 664-672 (2009). *

• Pierard-Franchimont C, Devillers C, Paquet P, Quatresooz P, Nikkels AF, Pierard GE. First line dermatological emergencies. Rev. Med. Liege. 63: 710-714 (2008).

• Pinna AL, Atzori L, Ferreli C, Aste N. Cutaneous Crohn disease in a child. Pediatr. Dermatol. 23: 49-52 (2006). *

• Pirat A, Ozgur S, Torgay A, Candan S, Zeyneloglu P, Arslan G. Risk factors for postoperative respiratory complications in adult liver transplant recipients. Transplant. Proc. 36: 218-220 (2004). *

• Planelles L, Medema JP, Hahne M, Hardenberg G. The expanding role of APRIL in cancer and immunity. Curr. Mol. Med. 8: 829-844 (2008).

• Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn's disease. An analysis of 79 cases. J. Clin. Gastroenterol. 13: 29-37 (1991).

• Pope JE. The diagnosis and treatment of Raynaud's phenomenon: a practical approach. Drugs 67: 517-525 (2007).

• Portincasa P, Vacca M, Moschetta A, Petruzzelli M, Palasciano G, van-Erpecum KJ, van-Berge-Henegouwen GP. Primary sclerosing cholangitis: updates in diagnosis and therapy. World J. Gastroenterol. 11: 7-16 (2005). *

• Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology 105: 1646-1651 (1998). *

• Poyet R, Kerebel S, Landais C, Aletti M, Graffin B, Paris JF, Carli P. Oedematous polyarthritis and myopericarditis as presenting features of periarteritis nodosa. Rev. Med. Interne. 30: 453-455 (2009).

• Prabhakaran S, Edgar MA, Diamond B, Hardin JA, Volpe BT. Overwhelming leukoencephalopathy as the only sign of neuropsychiatric lupus. J. Rheumatol. 32: 1843-1845 (2005).

• Prashant S, Kumar AS, Basheeruddin DD, Chowdhary TN, Madhu B. Cutaneous manifestations in patients suspected of chikungunya disease. Indian J. Dermatol. 54: 128-131 (2009). *

• Prince MA, Vialettes B, Zevaco-Mattei C, Vague P. Clinical characteristics and etiological markers in insulin-dependent diabetes associated with an organ-specific autoimmune disease. Acta Diabetol. Lat. 20: 221-229 (1983).

• Pula JH, Eggenberger E. Posterior reversible encephalopathy syndrome. Curr. Opin. Ophthalmol. 19: 479-484 (2008).

• Punwani S, Rodriguez-Justo M, Bainbridge A, Greenhalgh R, De Vita E, Bloom S, Cohen R, Windsor A, Obichere A, Hansmann A, Novelli M, Halligan S, Taylor SA. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 252: 712-720 (2009).

• Pytrus T, Iwanczak B, Smigiel R, Ryzko J, Socha P, Iwanczak F. Ascites and extreme lipid abnormalities as initial symptoms of cystic fibrosis in a 5-years-old girl - case report. Pol. Merkur. Lekarski. 27: 388-392 (2009).

• Qu-Hong, Brown LF, Dvorak HF, Dvorak AM. Ultrastructural immunogold localization of osteopontin in human gastric mucosa. J. Histochem. Cytochem. 45: 21-33 (1997). *

• Quaglietta L, te Velde A, Staiano A, Troncone R, Hommes DW. Functional consequences of NOD2/CARD15 mutations in Crohn disease. J. Pediatr. Gastroenterol. Nutr. 44: 529-539 (2007). *

• Quarta L, Corrado A, d'Onofrio F, Maruotti N, Cantatore FP. Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: the different pathological mechanisms. Rheumatol. Int. Jul 16 [Epub ahead of print] (2009). *

• Queiroz LS, Nascimento MS, Cruz AK, Castro AJ, Moura MD, Baseia IG, Araujo RM, Benevides NM, Lima LF, Leite EL. Glucans from the Caripia montagnei mushroom present anti-inflammatory activity. Int. Immunopharmacol. Oct 2 [Epub ahead of print] (2009).

• Quero Guillen JC, Carmona Soria I, Garcia Montes JM, Jimenez Saenz M, Herrerias Gutierrez JM. Hepatic encephalopathy: nomenclature, pathogenesis and treatment. Rev. Esp. Enferm. Dig. 95: 135-142, 127-134 (2003).

• Quillinan N, Mohammad A, Mannion G, O'Keeffe D, Bergin D, Coughlan R, Mc Dermott MF, McGonagle D. Imaging evidence for persistent subclincal fasciitis and arthritis in TNF receptor-associated periodic syndrome (TRAPS) between febrile attacks. Ann. Rheum. Dis. Nov 12 [Epub ahead of print] (2009).

• Radzikowska E, Szczepulska-Wojcik E, Chabowski M, Oniszh K, Langfort R, Roszkowski K. Pulmonary epithelioid haemangioendothelioma - interferon 2-alpha treatment - case report. Pneumonol. Alergol. Pol. 76: 281-285 (2008).

• Raederstorff D, Pantze M, Bachmann H, Moser U. Anti-inflammatory properties of docosahexaenoic and eicosapentaenoic acids in phorbol-ester-induced mouse ear inflammation. Int. Arch. Allergy Immunol. 111: 284-290 (1996).

• Rajasekhar L, Habibi S, Sudhakar P, Gumdal N. Lymphatic obstruction as a cause of extremity edema in systemic lupus erythematosus. Clin. Rheumatol. Sep 1 [Epub ahead of print] (2009). *

• Rajoriya N, Wotton CJ, Yeates DG, Travis SP, Goldacre MJ. Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. Postgrad. Med. J. 85: 233-237 (2009).

• Ramakers JD, Verstege MI, Thuijls G, Te Velde AA, Mensink RP, Plat J. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis. J. Clin. Immunol. 27: 275-283 (2007). *

• Ramanathan M, Abidin MN, Muthukumarappan M. The prevalence of skin manifestations in thyrotoxicosis - a retrospective study. Med. J. Malaysia 44: 324-328 (1989).

• Ramos GC, Fernandes D, Charao CT, Souza DG, Teixeira MM, Assreuy J. Apoptotic mimicry: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo. Br. J. Pharmacol. 151: 844-850 (2007). *

• Rashtak S, Pittelkow MR. Skin involvement in systemic autoimmune diseases. Curr. Dir. Autoimmun. 10: 344-358 (2008).

• Reddy NM, Suryanarayana V, Kalvakolanu DV, Yamamoto M, Kensler TW, Hassoun PM, Kleeberger SR, Reddy SP. Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice. J. Immunol. 183: 4601-4608 (2009).

• Rehak M, Fric E, Wiedemann P. Lutein and antioxidants in the prevention of age-related macular degeneration. Ophthalmologe 105: 37-45 (2008).

• Rejchrt S, Bures J, Siroky M, Kopacova M, Slezak L, Langr F. A prospective, observational study of colonic mucosal abnormalities associated with orally administered sodium phosphate for colon cleansing before colonoscopy. Gastrointest. Endosc. 59: 651-654 (2004). *

• Reniers DE, Howard JM. Isotretinoin-induced inflammatory bowel disease in an adolescent. Ann. Pharmacother. 35: 1214-1216 (2001).

• Requena L, Sanchez Yus E. Erythema nodosum. Semin. Cutan. Med. Surg. 26: 114-125 (2007).

• Resnick D, Krinsky GA, Lavelle MT, Lee VS, Keogan MT, Morrin MM. Do patients with primary sclerosing cholangitis have a greater frequency of pancreatic abnormalities at MRI than patients with other liver diseases? J. Comput. Assist. Tomogr. 26: 994-999 (2002).

• Rho YH, Woo JH, Choi SJ, Lee YH, Ji JD, Song GG. A new onset of systemic lupus erythematosus developed after bee venom therapy. Korean J. Intern. Med. 24: 283-285 (2009).

• Ribeiro CH, Lopez NC, Ramirez GA, Valck CE, Molina MC, Aguilar L, Rodriguez M, Maldonado I, Martinez R, Gonzalez C, Troncoso R, Lavandero S, Gingras AR, Schwaeble W, Ferreira A. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity. Mol. Immunol. 46: 1092-1099 (2009). *

• Ricci P, Therneau TM, Malinchoc M, Benson JT, Petz JL, Klintmalm GB, Crippin JS, Wiesner RH, Steers JL, Rakela J, Starzl TE, Dickson ER. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology 25: 672-677 (1997). *

• Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim Sh. Rosiglitazone for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 3: CD006063 (2007). *

• Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim Sh. Pioglitazone for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 4: CD006060 (2006). *

• Rimola J, Rodriguez S, Garcia Bosch O, Ordas I, Ayala E, Aceituno M, Pellise M, Ayuso C, Ricart E, Donoso L, Panes J. Magnetic resonance for assessment of disease activity and severity in Crohn disease. Gut 58: 1113-1120 (2009).

• Rimola J, Rodríguez S, García-Bosch O, Ricart E, Pages M, Pellise M, Ayuso C, Panes J. Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease. Radiographics 29: 701-719 (2009).

• Ritchlin CT, Proulx S, Schwarz ES. Translational perspectives on psoriatic arthritis. J. Rheumatol. Suppl. 83: 30-34 (2009).

• Robinson JG. Update on PPAR agonists: the clinical significance of FIELD and PROACTIVE. Curr. Atheroscler. Rep. 9: 64-71 (2007).

• Rocher F, Pelosse B, Momtchilova M, Laroche L. Kikuchi's disease and ocular manifestation. J. Fr. Ophtalmol. 29: 932-936 (2006).

• Rochman J, Chaimovitz C, Eidelman S, Better OS. Renal handling of sodium, water and divalent ions in patients with primary biliary cirrhosis. Adv. Exp. Med. Biol. 81: 121-129 (1977).

• Roe R, Branco BC, Cunningham ET Jr. Hypotony maculopathy in a patient with HLA-B27-associated uveitis. Ocul. Immunol. Inflamm. 16: 107-108 (2008).

• Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130: 1194-1205 (2007). *

• Roguedas AM, Crespel E, Kupfer I, De Saint Martin L, Misery L, Sassolas B. Bullous pemphigoid sparing acquired lymphedema. Ann. Dermatol. Venereol. 133: 250-252 (2006).

• Rohatagi S Ph D, Carrothers TJ, Jin JY, Jusko WJ, Khariton T, Walker J, Truitt K, Salazar DE. Model-based development of a PPARgamma agonist, rivoglitazone, to aid dose selection and optimize clinical trial designs. J. Clin. Pharmacol. 48: 1420-1429 (2008). *

• Romano A, De Santis A, Romito A, Di Fonso M, Venuti A, Gasbarrini GB, Manna R. Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes. Ann. Allergy Asthma Immunol. 80: 433-437 (1998). *

• Rottem M, Mader R. Successful use of etanercept in acquired angioedema in a patient with psoriatic arthritis. J. Rheumatol. 37: 209 (2010).

• Rouleau J, Longmuir R, Lee AG. Optic disc edema with adjacent cilioretinal artery occlusion in a male with ulcerative colitis. Semin. Ophthalmol. 22: 25-28 (2007).

• Rubegni P, Mandato F, Sbano P, Fimiani M. Terbinafine-induced acute generalized exanthematous pustulosis. G. Ital. Dermatol. Venereol. 143: 151-155 (2008).

• Rubenstrunk A, Hanf R, Hum DW, Fruchart JC, Staels B. Safety issues and prospects for future generations of PPAR modulators. Biochim. Biophys. Acta 1771: 1065-1081 (2007). *

• Rudick RA, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Radue EW, Lublin FD, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N. Engl. J. Med. 354: 911-923 (2006). *

• Ryan TJ. Elephantiasis, elastin, and chronic wound healing: 19th century and contemporary viewpoints relevant to hypotheses concerning lymphedema, leprosy, erysipelas, and psoriasis - review and reflections. Lymphology 42: 19-25 (2009).

• Ryschich E, Kerkadze V, Deduchovas O, Salnikova O, Parseliunas A, Marten A, Hartwig W, Sperandio M, Schmidt J. Intracapillary leukocyte accumulation as a novel antihemorrhagic mechanism in acute pancreatitis in mice. Gut 58: 1508-1516 (2009).

• Saadoun D, Wechsler B, Resche-Rigon M, Trad S, Le Thi Huong D, Sbai A, Dormont D, Amoura Z, Cacoub P, Piette JC. Cerebral venous thrombosis in Behcet's disease. Arthritis Rheum. 61: 518-526 (2009). *

• Saalman R, Mattsson U, Jontell M. Orofacial granulomatosis in childhood-a clinical entity that may indicate Crohn's disease as well as food allergy. Acta Paediatr. 98: 1162-1167 (2009).

• Saban MR, Simpson C, Davis CA, Wallis G, Knowlton N, Frank MB, Centola M, Gallucci RM, Saban R. Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG). BMC Immunol. 8: 6 (2007). *

• Saha M, Edmonds E, Martin J, Bunker CB. Penile lymphoedema in association with asymptomatic Crohn's disease. Clin. Exp. Dermatol. 34: 88-90 (2009). *

• Saito T, Mori Y, Yoshida M, Maeta T, Koui F, Harada M. Non-cardiogenic pulmonary oedema induced by salazosulfapyridine. Respirology 10: 545-547 (2005).

• Sakazaki F, Ueno H, Nakamuro K. 17beta-Estradiol enhances expression of inflammatory cytokines and inducible nitric oxide synthase in mouse contact hypersensitivity. Int. Immunopharmacol. 8: 654-660 (2008).

• Sale MM, Akamizu T, Howard TD, Yokota T, Nakao K, Mori T, Iwasaki H, Rich SS, Jennings-Gee JE, Yamada M, Bowden DW. Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population. Proc. Assoc. Am. Physicians 109: 453-461 (1997).

• Salonen JT, Uimari P, Aalto JM, Pirskanen M, Kaikkonen J, Todorova B, Hypponen J, Korhonen VP, Asikainen J, Devine C, Tuomainen TP, Luedemann J, Nauck M, Kerner W, Stephens RH, New JP, Ollier WE, Gibson JM, Payton A, Horan MA, Pendleton N, et al. Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am. J. Hum. Genet. 81: 338-345 (2007). *

• Sanchez-Fidalgo S, Villegas I, Martin A, Sanchez-Hidalgo M, Alarcon de la Lastra C. PARP inhibition reduces acute colonic inflammation in rats. Eur. J. Pharmacol. 563: 216-223 (2007). *

• Sanchez-Hidalgo M, Martin AR, Villegas I, Alarcon de la Lastra C. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Eur. J. Pharmacol. 562: 247-258 (2007). *

• Sandek A, Rauchhaus M, Anker SD, von Haehling S. The emerging role of the gut in chronic heart failure. Curr. Opin. Clin. Nutr. Metab. Care 11: 632-639 (2008).

• Sands BE, Winston BD, Salzberg B, Safdi M, Barish C, Wruble L, Wilkins R, Shapiro M, Schwertschlag US; RHIL-11 Crohn's Study group. Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease. Aliment. Pharmacol. Ther. 16: 399-406 (2002). *

• Sanghi S, Maclaughlin EJ, Jewell CW, Chaffer S, Naus PJ, Watson LE, Dostal DE. Cyclooxygenase-2 inhibitors: a painful lesson. Cardiovasc. Hematol. Disord. Drug Targets 6: 85-100 (2006).

• Sano F, Ozawa R, Machida H, Miyamae T, Ito S, Imagawa T, Mori M, Okuyama K, Yokota S. Two female siblings with childhood-onset systemic lupus erythematosus. Nihon Rinsho Meneki Gakkai Kaishi 31: 172-177 (2008).

• Sanyal AJ. Pros and cons of TIPS for refractory ascites. J. Hepatol. 43: 924-925 (2005). *

• Sastre Lopez A, Gago Gonzalez E, Banos Gallardo M, Gomez-Huertas E, Ortega Suarez F. All-trans retinoic acid sindrome and renal cortical necrosis. An. Med. Interna. 24: 550-552 (2007).

• Sawada N, Murata M, Kikuchi K, Osanai M, Tobioka H, Kojima T, Chiba H. Tight junctions and human diseases. Med. Electron Microsc. 36: 147-156 (2003). *

• Scagliusi P, Sisto M, Lisi S, Lazzari A, D'Amore M. Hashimoto's thyroiditis in Melkersson-Rosenthal syndrome patient: casual association or related diseases? Panminerva Med. 50: 255-257 (2008).

• Scalabrino G. The multi-faceted basis of vitamin B(12) (cobalamin) neurotrophism in adult central nervous system: lessons learned from its deficiency. Prog. Neurobiol. 88: 203-220 (2009).

• Scatizzi JC, Bickel E, Hutcheson J, Haines GK 3rd, Perlman H. Bim deficiency leads to exacerbation and prolongation of joint inflammation in experimental arthritis. Arthritis Rheum. 54: 3182-3193 (2006). *

• Scatizzi JC, Hutcheson J, Pope RM, Firestein GS, Koch AE, Mavers M, Smason A, Agrawal H, Haines GK 3rd, Chandel NS, Hotchkiss RS, Perlman H. Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis. Arthritis Rheum. 62: 441-451 (2010). *

• Schedel J, Mayer S, Woenckhaus M, Kiss E, Scholmerich J, Rogler G. Autoimmune cholangitis with vasculitic ulcers, rheumatoid arthritis and IgA glomerulonephritis. Dtsch. Med. Wochenschr. 129: 2409-2412 (2004).

• Scheinfeld N. Efalizumab: a review of events reported during clinical trials and side effects. Expert Opin. Drug Saf. 5: 197-209 (2006).

• Scheinfeld N, Bangalore S. Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin. J. Drugs Dermatol. 5: 467-468 (2006).

• Schinella G, Aquila S, Dade M, Giner R, Del Carmen Recio M, Spegazzini E, de Buschiazzo P, Tournier H, Rios JL. Anti-inflammatory and apoptotic activities of pomolic acid isolated from Cecropia pachystachya. Planta Med. 74: 215-220 (2008).

• Scholmerich J. Management of extraintestinal disease in IBD. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 38-39 (2005). *

• Scholz DG, Nagorney DM, Lindor KD. Poor outcome from peritoneovenous shunts for refractory ascites. Am. J. Gastroenterol. 84: 540-543 (1989).

• Schwarz EM, Proulx ST, Ritchlin CT, Boyce BF, Xing L. The role of bone marrow edema and lymphangiogenesis in inflammatory-erosive arthritis. Adv. Exp. Med. Biol. 658: 1-10 (2010). *

• Sebagh M, Yilmaz F, Karam V, Falissard B, Roche B, Azoulay D, Samuel D, Guettier C. The histologic pattern of "biliary tract pathology" is accurate for the diagnosis of biliary complications. Am. J. Surg. Pathol. 29: 318-323 (2005).

• Seki M, Kohno S, Newstead MW, Zeng X, Bhan U, Lukacs NW, Kunkel SL, Standiford TJ. Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J. Immunol. Dec 30 [Epub ahead of print] (2009).

• Selve N, Wohrmann T. Intestinal inflammation in TNBS sensitized rats as a model of chronic inflammatory bowel disease. Mediators Inflamm. 1: 121-126 (1992). *

• Semrad CE. Zinc and intestinal function. Curr. Gastroenterol. Rep. 1: 398-403 (1999).

• Sengler C, Keitzer R, Pleyer U. Uveitis in conjunction with rheumatological diseases in childhood. Ophthalmologe 102: 463-476 (2005).

• Serfaty L. Pioglitazone: the beginning of a new era for NASH? J. Hepatol. 47: 160-162 (2007). *

• Serkina EV, Gromova OA, Torshin II, Cotnikova NI, Nikonov AA. Cerebrolysin alleviates perinatal CNS disorders through the autoimmune modulation and antioxidant protection. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 108: 62-66 (2008).

• Sevgi E, Yalcin G, Kansu T, Varli K. Drug induced intracranial hypertension associated with sulphasalazine treatment. Headache 48: 296-298 (2008).

• Shafik A, Ahmed I, Shafik AA, El-Sibai O. Electric activity of the gut in ulcerative colitis and Crohn's disease: electromyography as a tool for differentiating between the two conditions in the early stage. Med. Sci. Monit. 10: CR572-CR576 (2004). *

• Shafran I, Burgunder P. Rifaximin for the treatment of newly diagnosed Crohn's disease: a case series. Am. J. Gastroenterol. 103: 2158-2160 (2008). *

• Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, Gonzalez FJ. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 134: 2036-2048 (2008). *

• Shams MG, Motamedi MH, Azizi T. Orofacial granulomatosis of the lower lip and cheek: report of a case. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 104: e42-e44 (2007).

• Sharif R, Dawra RK, Wasiluk K, Phillips P, Dudeja V, Kurt-Jones E, Finberg R, Saluja AK. Impact of Toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice. Gut 58: 813-819 (2009).

• Sharif S, Broman M, Babcock T, Ong E, Jho D, Rudnicki M, Helton WS, Espat NJ. A priori dietary omega-3 lipid supplementation results in local pancreatic macrophage and pulmonary inflammatory response attenuation in a model of experimental acute edematous pancreatitis (AEP). JPEN J. Parenter. Enteral Nutr. 30: 271-276 (2006). *

• Sharma AK, Laubach VE, Ramos SI, Zhao Y, Stukenborg G, Linden J, Kron IL, Yang Z. Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. Nov 10 [Epub ahead of print] (2009).

• Sharma M, Ray SM. Synthesis and biological evaluation of amide derivatives of (5,6-dimethoxy-2,3-dihydro-1H-inden-1-yl)acetic acid as anti-inflammatory agents with reduced gastrointestinal ulcerogenecity. Eur. J. Med. Chem. 43: 2092-2102 (2008). *

• Sharma RP, He Q, Riley RT. Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine. Toxicology 216: 59-71 (2005). *

• Sharma SD, Meeran SM, Katiyar N, Tisdale B, Yusuf N, Xu H, Elmets CA, Katiyar SK. IL-12-deficiency suppresses 12-O-tetradecanoylphorbol-13-acetate-induced skin tumor development in 7, 12-dimethylbenz(a)anthracene-initiated mouse skin through inhibition of inflammation. Carcinogenesis 30: 1970-1977 (2009). *

• Shen C, Bullens D, Kasran A, Maerten P, Boon L, Aerts JM, Van Assche G, Geboes K, Rutgeerts P, Ceuppens JL. Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis. Int. Immunopharmacol. 4: 939-951 (2004).

• Shen C, Dillissen E, Kasran A, Lin Y, Clydesdale G, Sienaert I, Jonghe SD, Gao LJ, Geboes K, Boon L, Rutgeerts P, Ceuppens JL. Anti-inflammatory activity of a pteridine derivative (4AZA2096) alleviates TNBS-induced colitis in mice. J. Interferon Cytokine Res. 26: 575-582 (2006).

• Shi JH, Liu W, Lu XH, Pan WD, Wang Y, Wu X, Wen XH, Qin MW. Diagnostic value of CT enterography in patients with Crohn's disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 31: 498-502 (2009).

• Shibata S, Ubara Y, Sawa N, Tagami T, Hosino J, Yokota M, Katori H, Takemoto F, Hara S, Takaichi K, Fujii A, Murata H, Nishi T. Severe interstitial cystitis associated with Sjogren's syndrome. Intern. Med. 43: 248-252 (2004). *

• Shichijo K, Shin T, Wen CY, Nakayama T, Nakashima M, Kaimovich AG, Matsuyama M, Sekine I. Expression of apoptotic epithelial cells in biopsy specimens of patients with colitis. Dig. Dis. Sci. 52: 2037-2043 (2007). *

• Shimazaki K, Jirawuthiworavong GV, Nguyen EV, Awazu M, Levinson RD, Gordon LK. Tubulointerstitial nephritis and uveitis syndrome: a case with an autoimmune reactivity against retinal and renal antigens. Ocul. Immunol. Inflamm. 16: 51-53 (2008).

• Shin SY, Lee JM. A case of multiple cranial nerve palsies as the initial ophthalmic presentation of antiphospholipid syndrome. Korean J. Ophthalmol. 20: 76-78 (2006).

• Shoari M, Katz BJ. Recurrent neuroretinitis in an adolescent with ulcerative colitis. J. Neuroophthalmol. 25: 286-288 (2005).

• Sidoroff A, Dunant A, Viboud C, Halevy S, Bavinck JN, Naldi L, Mockenhaupt M, Fagot JP, Roujeau JC. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br. J. Dermatol. 157: 989-996 (2007). *

• Sierra S, Lara-Villoslada F, Comalada M, Olivares M, Xaus J. Dietary fish oil n-3 fatty acids increase regulatory cytokine production and exert anti-inflammatory effects in two murine models of inflammation. Lipids 41: 1115-1125 (2006).

• Sigusch BW. Periodontitis as manifestation of Crohn's disease in primary dentition: a case report. J. Dent. Child. (Chic.) 71: 193-196 (2004).

• Simmons J. Crohn disease and ulcerative colitis. ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *

• Sina C, Arlt A, Gavrilova O, Midtling E, Kruse ML, Muerkoster SS, Kumar R, Folsch UR, Schreiber S, Rosenstiel P, Schafer H. Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB. Inflamm. Bowel Dis. 16: 320-331 (2010).

• Singh S, Khajuria A, Taneja SC, Khajuria RK, Singh J, Qazi GN. Boswellic acids and glucosamine show synergistic effect in preclinical anti-inflammatory study in rats. Bioorg. Med. Chem. Lett. 17: 3706-3711 (2007). *

• Sixdorf U, Bauer H, Marker-Hermann E. Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil. Dtsch. Med. Wochenschr. 131: 2266-2269 (2006).

• Slocum MM, Sittig KM, Specian RD, Deitch EA. Absence of intestinal bile promotes bacterial translocation. Am. Surg. 58: 305-310 (1992).

• Slonim AE, Bulone L, Damore MB, Goldberg T, Wingertzahn MA, McKinley MJ. A preliminary study of growth hormone therapy for Crohn's disease. N. Engl. J. Med. 342: 1633-1637 (2000).

• Smahi A, Courtois G, Rabia SH, Doffinger R, Bodemer C, Munnich A, Casanova JL, Israel A. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum. Mol. Genet. 11: 2371-2375 (2002). *

• Smyth D, Rehman R, Remund K, Egan J. Remitting seronegative symmetrical synovitis with pitting oedema associated with rifampicin. Ir. J. Med. Sci. May 9 [Epub ahead of print] (2009). *

• Solga SF. Probiotics can treat hepatic encephalopathy. Med. Hypotheses 61: 307-313 (2003). *

• Song MH, Kim MH, Jang SJ, Lee SK, Lee SS, Han J, Seo DW, Min YI, Song DE, Yu E. Comparison of histology and extracellular matrix between autoimmune and alcoholic chronic pancreatitis. Pancreas 30: 272-278 (2005).

• Soria A, Maubec E, Henry-Feugeas MC, Marinho E, Le Bozec P, Huisse MG, Pocidalo MA, Descamps V, Crickx B. Panniculitis induced by interferon beta vascular toxicity. Ann. Dermatol. Venereol. 134: 374-377 (2007).

• Sorrentino D, Avellini C, Beltrami CA, Pasqual E, Zearo E. Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease. Int. J. Colorectal Dis. 21: 276-281 (2006). *

• Sotiropoulos KB, Clermont A, Yasuda Y, Rask-Madsen C, Mastumoto M, Takahashi J, Vecchia KD, Kondo T, Aiello LP, King GL. Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain. FASEB J. 20: 1203-1205 (2006). *

• Southward J, Irvine E, Rabinovich M. Probable amlodipine-induced angioedema. Ann. Pharmacother. 43: 772-776 (2009).

• Spada C, Riccioni ME, Marchese M, Familiari P, Costamagna G. Isotretinoin-associated pan-enteritis. J. Clin. Gastroenterol. 42: 923-925 (2008).

• Spek CA, Ten Kate FJ, Te Velde AA. Factor V Leiden and the etiology of inflammatory bowel disease. Thromb. Haemost. 98: 670-673 (2007).

• Stahel PF, Smith WR, Bruchis J, Rabb CH. Peroxisome proliferator-activated receptors: "key" regulators of neuroinflammation after traumatic brain injury. PPAR Res. 2008: 538141 (2008). *

• Steiner SJ, Kleiman MB, Corkins MR, Christenson JC, Wheat LJ. Ileocecal histoplasmosis simulating Crohn disease in a patient with hyperimmunoglobulin E syndrome. Pediatr. Infect. Dis. J. 28: 744-746 (2009).

• Stern M, Wiedemann B, Wenzlaff P; the German CFQA Group. From registry to quality management: the German CF quality qssessment project 1995 2006. Eur. Respir. J. 31: 29-35 (2008).

• Stevens HP, Ostlere LS, Rustin MH. Systemic lupus erythematosus in association with ulcerative colitis: related autoimmune diseases. Br. J. Dermatol. 130: 385-389 (1994).

• Stewart LC, Doe SJ, Bourke SJ, Leech S. Aquagenic palmar wrinkling as a presenting feature of cystic fibrosis gene dysfunction. Clin. Exp. Dermatol. 34: e647-e649 (2009). *

• Stolina M, Adamu S, Ominsky M, Dwyer D, Asuncion F, Geng Z, Middleton S, Brown H, Pretorius J, Schett G, Bolon B, Feige U, Zack D, Kostenuik PJ. RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis. J. Bone Miner. Res. 20: 1756-1765 (2005). *

• Stone MA, White LM, Gladman DD, Inman RD, Chaya S, Lax M, Salonen D, Weber DA, Guthrie JA, Pomeroy E, Podbielski D, Keystone EC. Significance of clinical evaluation of the metacarpophalangeal joint in relation to synovial/bone pathology in rheumatoid and psoriatic arthritis detected by magnetic resonance imaging. J. Rheumatol. 36: 2751-2757 (2009).

• Suarez Fernandez G. Paratuberculose enteritis and Crohn's disease. An. R. Acad. Nac. Med. (Madr.) 124: 221-234 (2007).

• Sugisaki K, Maekawa S, Mori K, Ichii O, Kanda K, Tai M, Suzuki T, Ochiai H, Ejiri Y, Takahashi M, Hakozaki H. Self-limited colitis during the course of rubella and cytomegalovirus infection in an immunocompetent adult. Intern. Med. 43: 404-409 (2004). *

• Sulewski RJ Jr, Blyumin M, Kerdel FA. Acute generalized exanthematous pustulosis due to clindamycin. Dermatol. Online J. 14: 14 (2008). *

• Sun YP, Wang HH, He Q, Cho CH. Effect of passive cigarette smoking on colonic alpha7-nicotinic acetylcholine receptors in TNBS-induced colitis in rats. Digestion 76: 181-187 (2007). *

• Surrenti C, Pozzi M, Biagini MR, Franco C, Lombardo R, Avanzi G. Effects of plasma exchange (PE) in primary biliary cirrhosis (PBC). A pilot study. Hepatogastroenterology 37: 128-130 (1990).

• Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Hayashi T, Goto D, Matsumoto I, Sumida T. A new low-field extremity magnetic resonance imaging and proposed compact MRI score: evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis. Mod. Rheumatol. 19: 358-365 (2009). *

• Sveger T. Alpha-1-antitrypsin deficiency. Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 29 (2006). *

• Swanink CM, Vercoulen JH, Galama JM, Roos MT, Meyaard L, van der Ven-Jongekrijg J, de Nijs R, Bleijenberg G, Fennis JF, Miedema F, van der Meer JW. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. J. Infect. Dis. 173: 460-463 (1996).

• Swartz LM, Laffel LM. A teenage girl with cystic fibrosis-related diabetes, diabetic ketoacidosis, and cerebral edema. Pediatr. Diabetes 9: 426-430 (2008).

• Szczepaniak WS, Zhang Y, Hagerty S, Crow MT, Kesari P, Garcia JG, Choi AM, Simon BA, McVerry BJ. Sphingosine 1-phosphate rescues canine LPS-induced acute lung injury and alters systemic inflammatory cytokine production in vivo. Transl. Res. 152: 213-224 (2008). *

• Takechi U, Okada K, Uozumi T, Tsuji S. Longitudinally extensive spinal cord lesion in a case of neuro-Behcet disease. Rinsho Shinkeigaku 48: 48-51 (2008).

• Takeda K, Morioka D, Matsuo K, Endo I, Sekido H, Moroboshi T, Togo S, Shimada H. A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation. Transplant. Proc. 39: 3505-3508 (2007). *

• Takeuchi M, Iwasaki T, Kezuka T, Usui Y, Okunuki Y, Sakai JI, Goto H. Functional and morphological changes in the eyes of Behcet's patients with uveitis. Acta Ophthalmol. Jun 1 [Epub ahead of print] (2009).

• Talalay P, Fahey JW, Healy ZR, Wehage SL, Benedict AL, Min C, Dinkova-Kostova AT. Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc. Natl. Acad. Sci. U.S.A. 104: 17500-17505 (2007). *

• Tamion F, Richard V, Renet S, Thuillez C. Intestinal preconditionning prevents inflammatory response by moduling heme-oxygenase-1 expression in endotoxic shock model. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G1308-G1314 (2007). *

• Tan V, Stella D, Frydenberg H, Mow C, Nandurkar S, Gibson PR. Hypoalbuminaemia and coeliac disease. Gut 57: 922, 930 (2008).

• Tan YM, Ostergaard M, Doyle A, Dalbeth N, Lobo M, Reeves Q, Robinson E, Taylor WJ, Jones PB, Pui K, Lee J, McQueen FM. MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage. Arthritis Res. Ther. 11: R2 (2009). *

• Tassoni JP Jr, Fawaz KA, Johnston DE. Cirrhosis and portal hypertension in a patient with adult Niemann-Pick disease. Gastroenterology 100: 567-569 (1991).

• Tate MD, Deng YM, Jones JE, Anderson GP, Brooks AG, Reading PC. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J. Immunol. 183: 7441-7450 (2009).

• Taylor PC. MRI-detected bone marrow edema in early rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 4: 516-517 (2008).

• Theodossiadis PG, Liarakos VS, Sfikakis PP, Charonis A, Agrogiannis G, Kavantzas N, Vergados IA. Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit. Graefes Arch. Clin. Exp. Ophthalmol. 247: 273-281 (2009). *

• Theodossiadis PG, Markomichelakis NN, Sfikakis PP. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular iInflammation. Retina 27: 399-413 (2007).

• Thompson JS, Burnett DA, Markin RS, Vaughan WP. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease. Am. J. Gastroenterol. 83: 756-760 (1988).

• Thuesen AD, Kindt SE. Yellow nail syndrome. Ugeskr. Laeger. 170: 59 (2008).

• Tietmann C, Bissada NF. Aggressive periodontitis in a patient with chronic cutaneous lupus erythematosus: a case report. Quintessence Int. 37: 401-408 (2006).

• Tiwari S, Blasi ER, Heyen JR, McHarg AD, Ecelbarger CM. Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats. Pharmacol. Res. 57: 383-392 (2008). *

• Toblli JE, Findor J, Sorda J, Bruch Igartua E, Hasenclever K, Collado HD. Latent distal renal tubular acidosis (dRTA) in primary biliary cirrhosis (PBC) and chronic autoimmune hepatitis (CAH). Acta Gastroenterol. Latinoam. 23: 235-238 (1993).

• Tong D, Eather S, Manolios N. Psoriatic arthritis and chronic lymphoedema: treatment efficacy by adalimumab. Clin. Rheumatol. 28: 1349-1350 (2009). *

• Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL. Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch. Dermatol. 136: 1487-1494 (2000). *

• Totterman SM. Magnetic resonance imaging of psoriatic arthritis: insight from traditional and three-dimensional analysis. Curr. Rheumatol. Rep. 6: 317-321 (2004).

• Touitou I, Notarnicola C, Grandemange S. Identifying mutations in autoinflammatory diseases: towards novel genetic tests and therapies? Am. J. Pharmacogenomics 4: 109-118 (2004).

• Toussirot E, Wendling D. Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment options. Drugs Aging 22: 451-469 (2005).

• Trojet S, Mazlout H, Hamdouni M, Toumi A, Jebali F, Cheour M, El Afrit MA, Kraiem A. Retinal vasculitis in Crohn's disease: a case report. J. Fr. Ophtalmol. Dec 18 [Epub ahead of print] (2009).

• Tsiaousi ET, Hatzitolios AI, Trygonis SK, Savopoulos CG. Malnutrition in end stage liver disease: recommendations and nutritional support. J. Gastroenterol. Hepatol. 23: 527-533 (2008). *

• Tsironi E, Gatselis N, Kotoula MG, Zachou K, Pefkianaki M, Zacharaki F, Chatzoulis DZ, Dalekos GN. Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series. Cases J. 2: 159 (2009). *

• Tudor M, Jandric I, Marovic A, Gjurasin M, Perovic D, Radic B, Blagaic AB, Kolenc D, Brcic L, Zarkovic K, Seiwerth S, Sikiric P. Traumatic brain injury in mice and pentadecapeptide BPC 157 effect. Regul. Pept. Nov 17 [Epub ahead of print] (2009).

• Turcu AF, White JA, Kulaga ME, Skluth M, Gruss CB. Calcium channel blocker-associated small bowel angioedema. J. Clin. Gastroenterol. 43: 338-341 (2009).

• Turkcapar N, Ozyuncu N, Cinar K, Ensari A, Kucuk O, Idilman R, Duman N, Ozden A. A case of systemic lupus erythematosus presenting with protein-losing enteropathy. Turk. J. Gastroenterol. 17: 226-230 (2006). *

• Turpie B, Yoshimura T, Gulati A, Rios JD, Dartt DA, Masli S. Sjogren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice. Am. J. Pathol. 175: 1136-1147 (2009). *

• Tweezer-Zaks N, Ben-Horin S, Schiby G, Bank I, Levi Y, Livneh A, Langevitz P. Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association. Am. J. Med. Sci. 332: 308-313 (2006).

• Ueda H, Yamazaki C, Yamazaki M. A hydroxyl group of flavonoids affects oral anti-inflammatory activity and inhibition of systemic tumor necrosis factor-alpha production. Biosci. Biotechnol. Biochem. 68: 119-125 (2004). *

• Ukinc K, Bayraktar M, Gedik A. Hypothyroid Graves' disease complicated with elephantiasis nostras verrucosa (ENV): a case report and review of the literature. Endocrine 36: 6-9 (2009).

• Uzal FA, Fisher DJ, Saputo J, Sayeed S, McClane BA, Songer G, Trinh HT, Fernandez Miyakawa ME, Gard S. Ulcerative enterocolitis in two goats associated with enterotoxin- and beta2 toxin-positive Clostridium perfringens type D. J. Vet. Diagn. Invest. 20: 668-672 (2008).

• Valentincic NV, Kraut A, Rothova A. Vitreous hemorrhage in multiple sclerosis-associated uveitis. Ocul. Immunol. Inflamm. 15: 19-25 (2007).

• Valeyrie-Allanore L, Sassolas B, Roujeau JC. Drug-induced skin, nail and hair disorders. Drug Saf. 30: 1011-1030 (2007).

• van Baarle D, Tsegaye A, Miedema F, Akbar A. Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system. Immunol. Lett. 97: 19-29 (2005).

• Van Bodegraven AA, Pena AS. Treatment of extraintestinal manifestations in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 6: 201-212 (2003).

• van Dam GM, Gips CH, Reisman Y, Maas KW, Purmer IM, Huizenga JR, Verbaan BW. Major clinical events, signs and severity assessment scores related to actual survival in patients who died from primary biliary cirrhosis. A long-term historical cohort study. Hepatogastroenterology 46: 108-115 (1999).

• Van Den Bogaerde J, Cahill J, Emmanuel AV, Vaizey CJ, Talbot IC, Knight SC, Kamm MA. Gut mucosal response to food antigens in Crohn's disease. Aliment. Pharmacol. Ther. 16: 1903-1915 (2002). *

• Van den Brande JM, Braat H, van den Brink GR, Versteeg HH, Bauer CA, Hoedemaeker I, van Montfrans C, Hommes DW, Peppelenbosch MP, van Deventer SJ. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 124: 1774-1785 (2003). *

• van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, LaRosa GJ, Ulloa L, Tracey KJ, van der Poll T. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130: 1822-1830 (2006). *

• Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, Bachert C. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61: 1280-1289 (2006). *

• Vaquero J, Chung C, Blei AT. Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy. Ann. Hepatol. 2: 12-22 (2003). *

• Vaquero J, Chung C, Cahill ME, Blei AT. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin. Liver Dis. 23: 259-269 (2003).

• Vaquero J, Rose C, Butterworth RF. Keeping cool in acute liver failure: rationale for the use of mild hypothermia. J. Hepatol. 43: 1067-1077 (2005). *

• Vardareli E, Dundar E, Angin K, Saricam T, Inal M. Effects of intrarectal and intraperitoneal N(G)-nitro-L-arginine methyl ester treatment in 2,4,6-trinitrobenzenesulfonic acid induced colitis in rats. Exp. Toxicol. Pathol. 55: 271-276 (2003).

• Varga L, Biro A, Szeplaki G, Toth L, Horvath A, Fust G, Farkas H. Anti-cholesterol antibody levels in hereditary angioedema. J. Cell. Mol. Med. 11: 1377-1383 (2007). *

• Velez AM, Howard MS, Hashimoto T. Palm tissue displaying a polyclonal autoimmune response in patients affected by a new variant of endemic pemphigus foliaceus in Colombia, South America. Eur. J. Dermatol. Nov 4 [Epub ahead of print] (2009).

• Vergnolle N, Cellars L, Mencarelli A, Rizzo G, Swaminathan S, Beck P, Steinhoff M, Andrade-Gordon P, Bunnett NW, Hollenberg MD, Wallace JL, Cirino G, Fiorucci S. A role for proteinase-activated receptor-1 in inflammatory bowel diseases. J. Clin. Invest. 114: 1444-1456 (2004). *

• Vesela K, Honzik T, Hansikova H, Haeuptle MA, Semberova J, Stranak Z, Hennet T, Zeman J. A new case of ALG8 deficiency (CDG Ih). J. Inherit. Metab. Dis. Aug 18 [Epub ahead of print] (2009).

• Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann's disease). Orphanet J. Rare Dis. 3: 5 (2008). *

• Vinceneux P, Pouchot J. Familial Mediterranean fever among the autoimmune diseases. Presse. Med. 34: 947-957 (2005).

• Viremouneix L, Monneuse O, Gautier G, Gruner L, Giorgi R, Allaouchiche B, Pilleul F. Prospective evaluation of nonenhanced MR imaging in acute pancreatitis. J. Magn. Reson. Imaging 26: 331-338 (2007).

• Vogel Y, Bous JC, Winnekendonk G, Henning BF. Tuberculous peritonitis in a German patient with primary biliary cirrhosis: a case report. J. Med. Case Reports 2: 32 (2008). *

• von Jagow B, Kohnen T. Anterior optic neuropathy associated with adalimumab. Ophthalmologica 222: 292-294 (2008).

• Vos XG, Smit N, Endert E, Tijssen JG, Wiersinga WM. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study. Clin. Endocrinol. (Oxf.) 69: 311-317 (2008).

• Vuksic T, Zoricic I, Brcic L, Sever M, Klicek R, Radic B, Cesarec V, Berkopic L, Keller N, Blagaic AB, Kokic N, Jelic I, Geber J, Anic T, Seiwerth S, Sikiric P. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the rat. Surg. Today 37: 768-777 (2007).

• Wagner AH, Wittjen I, Stojanovic T, Middel P, Meingassner JG, Hecker M. Signal transducer and activator of transcription 1 decoy oligodeoxynucleotide suppression of contact hypersensitivity. J. Allergy Clin. Immunol. 121: 158-165.e5 (2008). *

• Wakamoto S, Fujihara M, Sakagawa H, Takahashi D, Niwa K, Morioka M, Sato S, Kato T, Azuma H, Ikeda H. Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA class II antibody. Transfusion 48: 2060-2068 (2008).

• Walberer M, Nedelmann M, Ritschel N, Mueller C, Tschernatsch M, Stolz E, Bachmann G, Blaes F, Gerriets T. Intravenous immunoglobulin reduces infarct volume but not edema formation in acute stroke. Neuroimmunomodulation 17: 97-102 (2009).

• Wallace JD, Abbott-Johnson WJ, Crawford DH, Barnard R, Potter JM, Cuneo RC. GH treatment in adults with chronic liver disease: a randomized, double-blind, placebo-controlled, cross-over study. J. Clin. Endocrinol. Metab. 87: 2751-2759 (2002). *

• Wallace JL, Caliendo G, Santagada V, Cirino G, Fiorucci S. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology 132: 261-271 (2007). *

• Wan YJ, Badr MZ. Inhibition of carrageenan-induced cutaneous inflammation by PPAR agonists is dependent on hepatocyte-specific retinoid X receptor alpha. PPAR Res. 2006: 96341 (2006). *

• Wang L, Wang CM, Hou LH, Dou GR, Wang YC, Hu XB, He F, Feng F, Zhang HW, Liang YM, Dou KF, Han H. Disruption of the transcription factor recombination signal-binding protein-Jkappa (RBP-J) leads to veno-occlusive disease and interfered liver regeneration in mice. Hepatology 49: 268-277 (2009). *

• Wang LJ, Chen SJ, Si JM. Intestinal mucosa protection of Muscovite on ulcerative colitis in rats. Zhongguo Zhong Yao Za Zhi 30: 1840-1844 (2005).

• Wang T, Fu F, Zhang L, Han B, Zhu M, Zhang X. Effects of escin on acute inflammation and the immune system in mice. Pharmacol. Rep. 61: 697-704 (2009). *

• Watanabe N, Sugimoto N, Matsushita A, Maeda A, Nagai K, Hanioka K, Takahashi T. Association of intestinal malignant lymphoma and ulcerative colitis. Intern. Med. 42: 1183-1187 (2003). *

• Weenig RH, Bruce AJ, McEvoy MT, Gibson LE, Davis MD. Neutrophilic dermatosis of the hands: four new cases and review of the literature. Int. J. Dermatol. 43: 95-102 (2004). *

• Welch TR, Blystone LW. C3 is central to the interstitial component of experimental immune complex glomerulonephritis. Clin. Immunol. 115: 80-84 (2005). *

• Wenczl E. Skin manifestations, treatment and rehabilitation in overweight and obesity. Orv. Hetil. 150: 1731-1738 (2009).

• Wiedemann A, Vocke F, Fitzgerald J, Markert U, Jeschke U, Lohse P, Toth B. Leptin gene (TTTC) microsatellite polymorphism as well as leptin receptor R223Q and PPARgamma2 P12A substitutions are not associated with hypertensive disorders in pregnancy. Am. J. Reprod. Immunol. Jan 12 [Epub ahead of print] (2010).

• Wiedemann B, Paul KD, Stern M, Wagner TO, Hirche TO. Evaluation of body mass index percentiles for assessment of malnutrition in children with cystic fibrosis. Eur. J. Clin. Nutr. 61: 759-768 (2007). *

• Williams R. Clinical management of acute liver failure. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 82 (2005). *

• Williams R, Riordan SM. Acute liver failure: established and putative hepatitis viruses and therapeutic implications. J. Gastroenterol. Hepatol. 15: G17-G25 (2000).

• Wilson KR, Napper JM, Denvir J, Sollars VE, Yu HD. Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages. Microbiology 153: 968-979 (2007). *

• Winfield H, Lain E, Horn T, Hoskyn J. Eosinophilic cellulitis-like reaction to subcutaneous etanercept injection. Arch. Dermatol. 142: 218-220 (2006). *

• Wirth HP, Heer P, Bertschinger P, Meyenberger C, Ammann R, Altorfer J. Transient eosinophilia in primary biliary cirrhosis. Schweiz. Med. Wochenschr. 123: 2278-2283 (1993).

• Wirth HP, Zala G, Meyenberger C, Ammann R. Significance of subtype pattern of antimitochondrial antibodies in primary biliary cirrhosis for prognostic parameters and response to ursodeoxycholic acid. Schweiz. Med. Wochenschr. 125: 750-754 (1995).

• Wolburg-Buchholz K, Mack AF, Steiner E, Pfeiffer F, Engelhardt B, Wolburg H. Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis. Acta Neuropathol. 118: 219-233 (2009).

• Woodruff TM, Arumugam TV, Shiels IA, Newman ML, Ross PA, Reid RC, Fairlie DP, Taylor SM. A potent and selective inhibitor of group IIa secretory phospholipase A(2) protects rats from TNBS-induced colitis. Int. Immunopharmacol. 5: 883-892 (2005).

• Woodruff TM, Arumugam TV, Shiels IA, Reid RC, Fairlie DP, Taylor SM. A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease. J. Immunol. 171: 5514-5520 (2003). *

• Woodruff TM, Pollitt S, Proctor LM, Stocks SZ, Manthey HD, Williams HM, Mahadevan IB, Shiels IA, Taylor SM. Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 314: 811-817 (2005). *

• Wu HG, Liu HR, Tan LY, Gong YJ, Shi Y, Zhao TP, Yi Y, Yang Y. Electroacupuncture and moxibustion promote neutrophil apoptosis and improve ulcerative colitis in rats. Dig. Dis. Sci. 52: 379-384 (2007). *

• Xia K, Wolf J, Friedman S, Carr-Locke DL. Granulomatous tracheo-bronchitis associated with Crohn's disease. MedGenMed. 6: 18 (2004). *

• Xiong GS, Wu SM, Wang ZH, Mo JZ, Xiao SD. Effects of thalidomide in experimental models of post-endoscopic retrograde cholangiopancreatography pancreatitis. J. Gastroenterol. Hepatol. 22: 371-376 (2007). *

• Xiong J, Zhu ZH, Liu JS, Wang Y, Wu HS. The expression of Toll-like receptor 2, 4 of livers in mice with systemic inflammatory response syndrome. Hepatobiliary Pancreat. Dis. Int. 5: 143-146 (2006). *

• Xu P, Zhou XJ, Chen LQ, Chen J, Xie Y, Lv LH, Hou XH. Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis. World J. Gastroenterol. 13: 1983-1988 (2007). *

• Xue Z, Wang X, Liu F, Hu S, Zhu S, Zhang S, Bu B. Intracranial hypertension syndrome in systemic lupus erythematosus: clinical analysis and review of the literature. J. Huazhong Univ. Sci. Technolog. Med. Sci. 29: 107-111 (2009).

• Yamada S, Bandai S, Masutani K, Tsuchimoto A, Noguchi H, Munakata M, Tsuruya K, Iida M. Focal segmental glomerulosclerosis in a patient with isolated ACTH deficiency and reversible hypothyroidism. Clin. Exp. Nephrol. Oct 7 [Epub ahead of print] (2009).

• Yamamoto M, Nojima M, Ohara M, Suzuki C, Naishiro Y, Itoh Y, Yamamoto H, Takahashi H, Kitajima Y, Endo T, Imai K. A case of systemic lupus erythematosus with postpartum hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome and concomitant high phosphatidylserine-dependent anti-prothrombin antibody levels. Mod. Rheumatol. 14: 402-405 (2004).

• Yamane T, Uchiyama K, Ishii T, Ishii H, Omura M, Fujise K, Tajiri H. Refractory diverticular colitis with progressive ulcerative colitis-like changes extending to the rectum. Dig. Endosc. 21: 188-191 (2009). *

• Yanaba K, Mukaida N, Matsushima K, Murphy PM, Takehara K, Sato S. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production. Eur. J. Immunol. 34: 3553-3561 (2004). *

• Yang DJ, Park YS, Yu YH, Jo YJ, Kim SH, Jung YY, Hwang YH, Jun DW. A case of renal vein thrombosis in a patient with ulcerative colitis. Korean J. Gastroenterol. 54: 248-251 (2009).

• Yang PC, Wang CS, An ZY. A murine model of ulcerative colitis: induced with sinusitis-derived superantigen and food allergen. BMC Gastroenterol. 5: 6 (2005). *

• Yang Z, Sharma AK, Linden J, Kron IL, Laubach VE. CD4(+) T lymphocytes mediate acute pulmonary ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 137: 695-702 (2009).

• Yang Z, Sharma AK, Marshall M, Kron IL, Laubach VE. NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Am. J. Respir. Cell. Mol. Biol. 40: 375-381 (2009). *

• Yasuoka H, Masuo T, Hashimoto K, Sato K, Okada S, Kusano M, Oishi T, Yokoo H, Kojima M, Nakazato Y, Mori M. Enteropathy-type T-cell lymphoma that was pathologically diagnosed as celiac disease. Intern. Med. 46: 1219-1224 (2007). *

• Yeh S, Karne NK, Kerkar SP, Heller CK, Palmer DC, Johnson LA, Li Z, Bishop RJ, Wong WT, Sherry RM, Yang JC, Dudley ME, Restifo NP, Rosenberg SA, Nussenblatt RB. Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. Ophthalmology 116: 981-989.e1 (2009).

• Yepes M, Winkles JA. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases. Drug News Perspect. 19: 589-595 (2006).

• Yildirim ND, Ayer M, Kucukkaya RD, Alpay N, Mete O, Yenerel MN, Yavuz AS, Nalcaci M. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma. Jpn. J. Clin. Oncol. 37: 704-707 (2007).

• Yin HC, Tseng HP, Chung HY, Ko CY, Tzou WS, Buhler DR, Hu CH. Influence of TCDD on zebrafish CYP1B1 transcription during development. Toxicol. Sci. 103: 158-168 (2008). *

• Yoshimura T, Sonoda KH, Sugahara M, Mochizuki Y, Enaida H, Oshima Y, Ueno A, Hata Y, Yoshida H, Ishibashi T. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 4: e8158 (2009). *

• Youn HS, Kim YS, Park ZY, Kim SY, Choi NY, Joung SM, Seo JA, Lim KM, Kwak MK, Hwang DH, Lee JY. Sulforaphane suppresses oligomerization of TLR4 in a thiol-dependent manner. J. Immunol. 184: 411-419 (2010).

• Youssef J, Badr M. Role of peroxisome proliferator-activated receptors in inflammation control. J. Biomed. Biotechnol. 2004: 156-166 (2004). *

• Yu JH, Kim KH, Kim H. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas. Int. J. Biochem. Cell Biol. 40: 677-688 (2008). *

• Yukawa S, Tahara K, Hayashi H, Tsuji S, Shoji A, Tsuboi N. A case of lupus cystitis in a 74-year-old woman. Nihon Rinsho Meneki Gakkai Kaishi 31: 183-189 (2008).

• Yumura Y, Oota J, Fujikawa A, Yokomizo Y, Moriyama M. The relationship between inflammatory bowel disease (IBD) and complications of urinary and male genital tracts. Hinyokika Kiyo 55: 677-683 (2009).

• Yun BC, Kim WR. Hyponatremia in hepatic encephalopathy: an accomplice or innocent bystander? Am. J. Gastroenterol. 104: 1390-1391 (2009). *

• Yun KJ, Koh DJ, Kim SH, Park SJ, Ryu JH, Kim DG, Lee JY, Lee KT. Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-kappaB inactivation. J. Agric. Food Chem. 56: 10265-10272 (2008). *

• Zamani F, Amiri A, Shakeri R, Zare A, Mohamadnejad M. Celiac disease as a potential cause of idiopathic portal hypertension: a case report. J. Med. Case Reports 3: 68 (2009). *

• Zare F, Magnusson M, Bergstrom T, Brisslert M, Josefsson E, Karlsson A, Tarkowski A. Uric acid, a nucleic acid degradation product, down-regulates dsRNA-triggered arthritis. J. Leukoc. Biol. 79: 482-488 (2006). *

• Zedan M, El-Ayouty M, Abdel-Hady H, Shouman B, El-Assmy M, Fouda A. Anasarca: not a nephrotic syndrome but dermatomyositis. Eur. J. Pediatr. 167: 831-834 (2008).

• Zedek D, Morrell DS, Graham M, Goodman D, Groben P. Acrodermatitis enteropathica-like eruption and failure to thrive as presenting signs of cystic fibrosis. J. Am. Acad. Dermatol. 58: S5-S8 (2008).

• Zelhof B, Biyani CS, Anathhanam AJ, Pollock B, Browning AJ. Severe penile edema: an unusual presentation of metastatic Crohn disease. Int. J. Urol. 13: 189-191 (2006).

• Zeng HY, Green WR, Tso MO. Microglial activation in human diabetic retinopathy. Arch. Ophthalmol. 126: 227-232 (2008).

• Zhaboedov GD, Kopaenko AI. Impaired antiendotoxin immunity in patients with diabetic retinopathy and type 2 diabetes mellitus. Vestn. Oftalmol. 121: 29-31 (2005).

• Zhang HY, Han DW, Zhao ZF, Liu MS, Wu YJ, Chen XM, Ji C. Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia. World J. Gastroenterol. 13: 3500-3507 (2007). *

• Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, Haug JS, Rupp D, Porter-Westpfahl KS, Wiedemann LM, Wu H, Li L. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441: 518-522 (2006). *

• Zhang XP, Ye Q, Jiang XG, Ma ML, Zhu FB, Zhang RP, Cheng QH. Preparation method of an ideal model of multiple organ injury of rat with severe acute pancreatitis. World J. Gastroenterol. 13: 4566-4573 (2007). *

• Zhang XW, Liu X, Li ZG. Clinical features of undifferentiated connective tissue diseases: analysis of 145 patients. Zhonghua Yi Xue Za Zhi 86: 2458-2461 (2006).

• Zheng JJ, Chu XQ, Shi XH, Wang YM, Jia LM, Zhou CL, Wang FM. Importance of colonoscopy combined with biopsy in the diagnosis of colonic Crohn's disease. Zhonghua Yi Xue Za Zhi 85: 1970-1973 (2005).

• Zheng JJ, Cu XQ, Shi XH, Wang YM, Jia LM, Zhou XL, Wang FM. Colonoscopic and histologic features of colonic Crohn's disease in Chinese patients. Chin. J. Dig. Dis. 8: 35-41 (2007).

• Zhenglu W, Hui L, Shuying Zh, Wenjuan C, Zhongyang Sh. A clinical-pathological analysis of drug-induced hepatic injury after liver transplantation. Transplant. Proc. 39: 3287-3291 (2007).

• Zhong Y, Liu Z, Henderson A, Lee K, Hostetter J, Wannemuehler M, Hendrich S. Increased CYP4B1 mRNA is associated with the inhibition of dextran sulfate sodium-induced colitis by caffeic acid in mice. Exp. Biol. Med. (Maywood) 234: 605-616 (2009). *

• Zhou HY, Shin EM, Guo LY, Zou LB, Xu GH, Lee SH, Ze KR, Kim EK, Kang SS, Kim YS. Anti-inflammatory activity of 21(alpha, beta)-methylmelianodiols, novel compounds from Poncirus trifoliata Rafinesque. Eur. J. Pharmacol. 572: 239-248 (2007).

• Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. MMWR Surveill. Summ. 52: 1-24 (2003).

• Ziegelbauer K, Gantner F, Lukacs NW, Berlin A, Fuchikami K, Niki T, Sakai K, Inbe H, Takeshita K, Ishimori M, Komura H, Murata T, Lowinger T, Bacon KB. A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity. Br. J. Pharmacol. 145: 178-192 (2005). *

• Zimmermann A. Consequences of cholestasis from the pathologist's viewpoint. Schweiz. Med. Wochenschr. 127: 812-820 (1997).

• Zimmermann R, Witte A, Voll RE, Strobel J, Frieser M. Coagulation activation and fluid retention associated with the use of black cohosh: a case study. Climacteric Jul 31 [Epub ahead of print] (2009).

• Zingale LC, Beltrami L, Zanichelli A, Maggioni L, Pappalardo E, Cicardi B, Cicardi M. Angioedema without urticaria: a large clinical survey. CMAJ 175: 1065-1070 (2006). *

• Zivadinov R, Cox JL. Neuroimaging in multiple sclerosis. Int. Rev. Neurobiol. 79C: 449-474 (2007).

• Zivadinov R, Sepcic J. Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis. Lijec. Vjesn. 128: 295-308 (2006).

Number of references = 871

www psc-literature.org